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INTRODUCTION
CHSMISTKY ( F H 'PARIN
Although heparin is not strictly a structural
✓
component ol' connective tissue, it is closely related to
heparan sulphate which is found throughout the body in such 
locations as cartilage and bone (Meyer et al., 1956), 
granulation tissue (Hcrenson &. Dalferes, I960), cervix uteri 
(Loewi <& Consden, 1962) and aorta, where it is involved in 
the ageing process (Kaplan A Meyer, i960).
Heparin and heparan sulphate are composed of equimolar
amounts of hexosaiine and hexuronic acid, when their uronic
acid content is determined by the decarboxylation method 
(Tracey, 19^8). While heparin is similar to the chondroitin 
sulphates in this respect, Volfrom and coworkers (1950) 
demonstrated that 1-3 hexosaminide linkages could not exist
in heparin since, during treatment with periodic acid, which
is specific for glycol groups, all the uronic acid is
destroyed. Moreover, experiments using heparin-adapted 
enzymes from Flavobacteria (Hoffman et al., 1957? Linker et 
al., i960; Linker da Sampson, i960) indicate that these 
linkages arc of the 1-4 type. This was later confirmed by 
Foster et al., (1961) by the isolation of erythronic acid 
from heparin hydrolysates after periodic acid treatment.
The uronide linkages in heparin cannot be of the 1-3
type, since 3-0-methylglucose has been isolated from hydro-
2lysate s of methylated heparin (Nomine, Burcout & Bertin,
1961). Furthermore, oligosaccharides obtained after partial 
hydrolysis of heparin do not show the shift in absorption 
maximum from 5^0 to 310 mu in the riion*Morgan reaction which 
is characteristic of 3-0-substituted hexosaminee (Danishefsky, 
Fiber ? Langholtz, I960; Cifonelli A Dorfnian, 196l)• The 
majority of these linkages appear to be of the 1-4 type since 
a disacchariae has been isolated from partial hydrolysates of
desulphated carboxyl-reduced hoparin, which gives half of the 
theoretical yield in the fIson-Morgan reaction (l olfrorn, 
Vercelloti & Horton, 19d2). The N-acetylated derivative, on 
the other hand, gives no colour in the Morgan-Elson reaction 
(\minoff et al., 1952). This behaviour is characteristic of 
4-substituted hexosamines. \lthough 1-4 linkages predominate 
in heparin, a small proportion of 1-6 type has been 
demonstrated in some preparations (Danishefsky, Fiber &
Illiams, 19^3)•
The amino grou; s of heparin are sulphated, unlike the
other glycosaminoglycans which have N-acetyl groups. Most
heparin preparations contain an average sulphate content of 
five groups per tetrasaccharide (Muir, 1964), although their 
precise location has yet to be unequivocally established. It
has even been supyested that these groujs /ay not be covalently 
attached to the heparin chain (llelbert c Marini, 1964).
This hypothesis now appears unli ely (Stivala et al., 1967)* 
This problem is made even more complex due to the variation in
sulphur content of different preparations, and possible species 
differences (Walton, Ricketts & Bangham, 1966). Foster and 
coworkers (1961), however, have demonstrated that the majority 
of the sulphate groups occur at the position of the 
hexuronic acid moiety, although a smaller proportion has been 
detected at the position (Durant, Hendrickson & Montgomery, 
1962)• The remainder of the sulphate groups appear to be 
located at the position of the hexosamine (Muir, 1964)•
At this time, therefore, a structure for the heparin
molecule, based on a tetrasaccharide unit, was beginning to
emerge, as shown below:-
OSO^H OSO^H
* minor component.
In this model heparin appears to be basically similar 
to the other mucopolysaccharides, save in its N-sulphation 
and variable degree of ester sulphation*
In the light of subsequent research, however, this 
model has received a sharp set-back. The uronic acid moiety 
of heparin, when determined by the cabazole method (Diache,
4.
19^7 I Bitter & Muir, 1962), appears to produce a colour yield 
appreciably higher than that obtained from other mucopoly­
saccharides. This anomaly can be explained by either the
presence of another hexuronic acid in addition to glucuronic
acid, or by some property of heparin which creates an artifact.I
It has been suggested that, in fact, this phenomenon is due 
to the N-sulphate groups (Linker et al., 1958), but more recent 
research, using de-N-sulphated heparin does not support this 
finding (Danishefsky et al., 1962). Cifonelli & Dorfman (1962) 
first reported the presence of iduronic acid in heparin, and
this component has received a great deal of attention in recent
years. Iduronic acid has been detected in the degradation 
products of heparin treated with a Flavobacterium Heparinum 
enzyme (Dietrich, 1968), and an iduronic acid to glucuronic 
acid ratio of It 2.6 has been reported in heparin analysed by 
gas liquid chromatography (Radhakrishnamurthy et al., 1968a). 
Wolfrom and coworkers (1969) have isolated and crystallised 
iduronic acid from chemically degraded heparin and confirmed
its identity by various chemical tests. These workers have 
also reported an iduronic acid content of 32$, and suggest 
that previous degradation procedures have been insufficiently
mild to allow its isolation. Furthermore, on the basis of a 
proton magnetic resonance study, Perlin et al., (1968) have 
suggested that the heparin molecule is composed of a repeating
trisaccharide of iduronic acid, glucuronic acid and gluco­
5
samine in equimolar concentrations.
In contrast to the widely held belief that the gluco­
samine content of heparin is exclusively N-sulphated•
Lindahl (1966b) has demonstrated that the amino sugars in the 
heparin-protein linkage region are N-acetylated in most cases, 
and gas liquid chromatography indicates that around 20$ of the 
total hexosamine molecules are N-acetylated (Radhakrishna- 
murthy et al., 1968b), while a galactosamine content of 5»6$ 
of the total hexosamine has also been demonstrated (Radhakrish- 
namurthy et al., 1968a).
The precise location of the ester sulphate groups of 
heparin remains confused. Dietrich (1968) has identified 
glucosamine-2,6-disulphate and glucuronic acid-3-sulphate in 
the digestion products of heparin treated with a heparinase
from Flavobacterium Heparinum. The localisation of ester
sulphate at the position of the hexosamine has recently 
been confirmed by chemical techniques (Wolfrom et al., 19691 
Danishefsky et al., 1969)» but Danishefsky and coworkers (1969) 
have reported the isolation of glucosamine with sulphate groups 
in the and positions and C2-sulphated glucuronic acid.
In recent years a considerable amount of research has
been performed on the heparin-protein linkage region.
Lindahl et al., (1965) from their study of crude commercial 
heparin preparations, isolated mainly from pig tissues and
containing residual peptides, reported that serine was the
predominant amino acid component. After chromatographic
6
analysis of hydrolysates of these heparin samples, two carbo- 
hydrate-serine compounds were identified, namely xylosylserine 
and galactosylxylosylserlne (Lindahl A Roden, 1965) and, on 
the basis of this result, the following structure for the
heparin-protein linkage region was proposed.
Glucuronic Acid-Glucosamine-Glucuronic Acid-Galactose
p.ptid.
S.rin.-Xylc.-Galacto..
Peptide
Lindahl (1966a) Isolated O-p-D xylopyranosyl-L-serine 
and 4-O-p-D-galactopyranosyl-O-p-D-xylopyranosyl-L-serine, 
thus identifying the configuration of the sugars. Further 
research (Lindahl, 1966b) Indicated that the amino-sugars are 
N-acetylated, and two of these molecules are involved either
in or near the linkage region. Moreover, all molecules in
this area are devoid of any covalent sulphate indicating
Incomplete sulphation. In addition, iduronlc acid has been
detected in some of the carbohydrate-serine compounds Isolated
after hydrolysis.
More recently, Lindahl (1968) has demonstrated that 
the major disaccharide component of the linkage region is 
glucuronic acid 1-4 glucosamine, that is the same basic unit 
as that suggested by Danishefsky A Steiner (1965) for the 
heparin molecule as a whole, except that the amino groups are 
N-acetylated. Furthermore, the previous model was revised to 
contain two glucuronic acid residues next to the terminal
galactose molecule.
It is evident, therefore, that, although the area near
to the linkage to protein has been clarified, much confusion
remains concerring the structure of the remainder of the
heparin molecule. The precise location of its iduronic acid 
moiety has yet to be conclusively identified, and sulphate
groups have been detected at almost every available hydroxyl
group. Furthermore, a small galactosamine component is
normally found during heparin analysis, but no location has
yet been postulated for this compound.
Undoubtedly much of the difficulty experienced in the
determination of the structure of heparin is caused by the
reliance on commercial or laboratory preparations isolated
using alkali, proteolytic enzymes or by autolysis and these
methods would be expected to cause damage to the material.
Species differences must also create problems, and it must
be remembered that heparin is an intracellular glycosamino-
glycan so that many molecular species may be present,
representing various stages in the biosynthesis of the molecule
These problems are reflected in the wide variation in molecular
weight and biological activity of different preparations.
7.
8PHYSICAL CHEMISTRY OF HEPARIN.
The blood anticoagulant activity of heparin has been
generally accepted for some time, and the majority of physico­
chemical Investigations have been concerned with this property
of the glycosamlnoglycan• This type of study has been
complicated by the extreme heterogeniety of the commercial
preparations normally employed, but some studies on fractionated
heparins demonstrate some interesting physical parameters of
the heparin molecule itself*
Reported values for the molecular weight of heparin
exhibit wide variations* Light scattering experiments give 
molecular weights between 10000 and 19700 (Barlow, Sanderson 
A McNeill, 1961; Ascoli, Botre A Liquori, 1961), while values 
between 4000 and 17000 have been reported for the sedimentation 
equilibrium method (Laurent, 196l| Lasker A Stivala, 1966; 
Braswell, 1968).
Studies on fractionated bovine heparin (Lasker A 
Stivala, 1966) reveal that a commercial preparation can be 
separated into four fractions on ECTEOLA, with molecular 
weights ranging from 8460-15680, but when the same preparation 
is subjected to fractional alcohol precipitation, twelve ‘ 
fractions are obtained with molecular weights between 4000 
and 13970, the molecular weights in both cases being measured
by equilibrium sedimentation* Biological activity assays on
these fractions showed that the higher the molecular weight,
the higher the biological activity. Viscosity measurements
9
were also performed on the fractions, and the data obtained,
when correlated with the molecular weights, indicated that
the heparin molecule exhibits considerable flexibility.
Further experiments using bovine heparin fractionated 
using ethanol and dioxane as precipitating agents (Libert! & 
Stivala, 1967) produced fractions varying in molecular weight 
between 4500 and 15500. It was reported that biological 
activity varied with molecular weight in fractions up to 
10000, but no appreciable difference was observed with fractions
exhibiting molecular weights in excess of that figure.
Further viscometric data suggested that the heparin molecule 
is fully extended in water, and consists of a single unbranched 
linear chain. The results of visconietry carried out in salt 
solutions confirmed earlier results (Lasker & Stivala, 1966) 
that the heparin molecule exhibits considerable flexibility.
Low angle X-ray scattering studies on a fraction 
precipitated in an ethanol-dioxane system (stivala et al.,
1968) give a molecular weight of 12900, which is in good 
agreement with molecular weights of 12600 and 12500 for the 
same fraction when measured by sedimentation equilibrium and 
viscosity (Lasker & Stivala, 1966). A persistence length of 
21. iX and a radius of gyration of 35*9$ were also determined, 
while the molecule was reported to behave in water as a 
Gaussian coil with a length of 237^ to 245X.
Braswell (1968) has reported heparin fractions varying 
Furthermore,in molecular weight between 8180 and 17000
the author suggests that the values reported by Lasker & 
Stivala (1966) may be considerably low due to the omission of 
a correction factor in their calculations. During his
experiments Braswell found no correlation between molecular
weight and biological activity.
During graded self hydrolysis of heparin (Stivala et 
al., 1967) the loss in anticoagulant activity is accompanied 
by a corresponding reduction in sedimentation coefficient,
intrinsic viscosity in water and a decrease in the axial 
ratios a/b, if a prolate ellipsoid molecule is assumed.
The viscosity in 0.5M-NaCl, however, is not affected, 
indicating that the decrease in molecular weight is caused 
by desulphation and not depolymerisation. Copper ion binding 
studies (Stivala di Liberti, 1967) revealed an increased uptake 
with increasing pH and biological activity, suggesting that
the anticoagulant activity of heparin is dependent on the
degree of dissociation of ionisable groups, including carboxyl
groups, and its molecular size and shape. These results
were essentially confirmed in similar experiments employing 
mild acid hydrolysis (Braswell, 1968).
Gauthier et al., (1969)» however, have reported that
at a certain point during mild acid hydrolysis at 25°C, 96%> 
of the dye binding capacity of heparin is retained, whilst its
biological activity is reduced by 70 >• Since in these
10.
experiments only 2% of the sulphate groups account for
approximately 70^ of the anticoagulant activity, these authors 
suggest the possibility of key bonds within the heparin
molecule•
The vast distribution of molecular weights observed
in all of the above Investigations indicates that a
considerable degree of degradation is occurring during the 
extraction of heparin. If degradation of this type, which
appears to be causing a certain amount of depolymerisation,
is taking place, then it is equally likely that many changes
in chemical composition and physico-chemical parameters may
also occur. Thus it is important that these data, valuable
as they are, are treated with a degree of caution since they 
may apply to a compound very different from heparin in its
11.
native state
12.
THE PROTEIN COMPLEX OF HEPARIN
Although the glycosaminoglycan-protein complex 
containing chondroitin 4-sulphate has been extensively 
characterized (Schatton & Schubert, 195^*1 Mathews A 
Lozaityte, 1958) and other complexes having chondroitin 6- 
sulphate (Buddecke & Schubert, 1961; Mathews, 1962) and 
hyaluronic acid (Ogsten & Sherman, 1958; Pigman, Rizvi A 
Holley, 1961j Sandson & Hammerman, 1962) as the poly­
saccharide moieties have been studied, the situation with
regard to native heparin-protein complexes has yet to be
clarified.
Perhaps the most significant previous attempt to
isolate the native heparin-protein complex is that of Julen, 
Snellman & Sylve^ (l95O)« In the supernatant of a phosphate- 
buffer extract of ox liver capsule, after centrifugation at 
60000g, protein and lipid, in addition to heparin, were 
detected. From these findings Julen et al., (1950) concluded 
that the native heparin-protein complex exists in a lipo­
protein form. However, the protein component was dissociated
from the complex and precipitated by saturation with phosphate 
ions (Snellman, Sylven & Julen, 1951)• indicating the absence
of covalent linkages. It is therefore considered, in
agreement with Korn (1959)• that this complex is a methodo­
logical artifact, due to the established affinity of heparin 
for lipoproteins (Bernfield, Donahue & Berkowitz, 1957)*
Green, Day A Roberts (1961) reported the presence of
13.
ninhydrin-sensitive spots in paper chromatograms of heparin 
hydrolysates and postulated the presence of amino acids 
covalently bound to carbohydrate* These results were 
confirmed by Lindahl et al., (1965)• who demonstrated the 
presence of serine-rich peptides bound to heparin in 
preparations isolated using either proteolytic enzymes or 
alkali. Lindahl & Roden (1965) also proved that the two 
moieties are covalently bound through a xylosylserine linkage, 
and suggested the existence of a native heparin-protein 
complex. Korn (1959)» however, found no evidence for such 
covalent complexes in his study of heparin isolated from 
mast cell tumours. Lagunoff (1965). on the other hand, 
isolated a very small amount of a heparin-protein complex, 
and suggested that the heparin and protein were covalently
bound. Furthermore, the existence of a heparin-protein
complex in the matrix of the mast cell granules has been 
proposed on the evidence that a fraction extracted by 
potassium chloride from isolated organelles contained both 
heparin and protein (Lloyd, Bloom & Balazs, 1967).
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MAST CELLS,
Mast cells were first recognized and described by 
von Recklinghausen (1863) in unstained specimens of frog 
mesentery. Furthermore, Waldeyer (1875) reported that in 
connective tissue, in addition to fibroblasts, granular cells
exhibiting an "embryonal" appearance were also present. The 
name "Mast Cell" was first used by Ehrlich (1879)• who reported 
that these cells could be distinguished by their metachroinatic
granules which he believed, at that time, to be the product of
overfeeding.
In 1937* Jorpes et al. demonstrated that heparin,
isolated from dog liver, stains metachromatically with toluidln
blue and, in addition, that there was a good correlation 
between the heparin content and the mast cell count of various 
tissues. It had been previously reported (Biedl & Kraus,
1909) that, during peptone shock in dogs, the blood clotting 
time was considerably increased. Wilander (1939) observed 
that the hepatic mast cells of the dog also discharge their 
granules during peptone shock, while Jacques <& Waters (19^1) 
found that this was accompanied by the release of heparin
from the liver.
Riley & West (1953) showed that the histamine content 
of various tissues is related to their mast cell count, and 
Benditt, Bader & Lam (1955) demonstrated that during ana­
phylactic inflammation, the discharge of the mast granules 
parallels the reduction in tissue histamine. Benditt and
15
coworkers (1955) also demonstrated the presence of 5-hydroxy- 
tryptamine in mast cells.
The localization of heparin, histamine and 5-hydroxy- 
tryptamine within the mast cell granule was established by 
Hagen, Barrnet & Lee (1959) using electron microscopical 
investigations together with ultracentrifugation, biochemical 
and biological assays. The concentration of these components 
in an average rat mast cell (expressed as microraicrogranis 
per mast cell) have been reported to be in the rangei 
heparin 30-^0, histamine 12-31 and 5-hydroxytryptamine 0.9- 
1.3 (Benditt et al., 19555 Benditt, Arase A Roeper, 1956$ 
Moran, Uvnfts A Westerholm, 1962j Humphrey, Austen & Rapp, 
1963.).
In addition to these major components many enzymes
have been demonstrated to be present in the mast coll granules.
The most studied enzymes are the chymotrypsin-like and
trypsin-like proteases. A chymotrypsin-like enzyme has been 
isolated from rat peritoneal mast cells (Benditt A Arase,
1959; Lagunoff A Benditt, 1963)» rat thyroid (Pastan & 
Almqvist, 1966) and dog mastocytomas (Lagunoff & Benditt,
19635 Auditore, Ende & Katayama, 19635 Katayaraa A Ends,
1965) and the trypsin-like enzyme has been isolated from 
human spleen (Ende A Auditore, 1961) and several dog masto­
cytomas (Lagunoff A Benditt, 19635 Katayaraa A Ende, 1965) ♦ 
Conclusive evidence for the granule localization of the
chymotrypsin-like enzyme has been provided by analyses of the
16
distribution of the enzyme in subcellular fractions of
sonically disrupted mast cells (Lagunoff & Benditt, 1963$ 
Lagunoff et alM 1964). It has been calculated to occupy 10% 
of the dry weight of the granule (Darzynkiewicz & Bernard,
19^7? Lagunoff, 1968), and has a pH optimum of 8.0 and a 
molecular weight of 2J000 (Pastan and Almqvist, 1966). The 
localization of this enzyme within the mast cell granule has
been studied In preparations of rat peritoneal mast cells 
(Lagunoff, 1965)• It appears to be bound, in the fully active 
form, to the heparin-protein matrix.
Other enzymes known to be present in mast cell granules 
include hydroxylases (Jordon & Hartman, 1962| Levine et al., 
1964), B«glucuronidase (Lutzner, 1964), succinic dehydrogenase 
(Glick & Pothapragada, 1961), phosphatidase (Keller, 1962; 
Anggard et al., 1963) and an enzyme which oxidised cyst(e)ine 
to cysteic acid (wheldrake & Pasternak, 1968).
The electron microscopic appearance of mast cells does 
not differ essentially from other cells, except in the 
possession of specific granules (Selye, 1964). The typical 
mast cell has a mean diameter of approximately 15 u, and 
contains a single, sometimes indented nucleus, a poorly 
developed endoplasmic reticulum and Golgi apparatus. It 
contains relatively few mitochondria which are often positioned 
adjacent to the nucleus. The nuclear and cell membranes 
appear to be double and the cell surface frequently exhibits
villosities
17
The majority of mast cell granules are very electron 
dense and exhibit a homogeneous granular appearance in the 
electron microscope (Thiery, 19631 Bloom & Haegermark,
19651 Veinstock & Albright, 1967} Kobayasi et al., 1968).
The size of the granules varies between 0.4 and 1.2 u (Bloom 
& Haegermark, 1965) and in some cases two types have been 
identified} a simple granule with a homogeneous granular 
appearance and a compound granule containing several areas 
of different appearance (Veinstock de Albright, 1967)• In 
certain granules, mainly from human or guinea pig specimens,
elongated cylindrical or scroll-like lamellae have been 
observed (Stockenius, 1956} Veinstock A Albright, 19671 
Brinkman, 1968} Kobayasi et al., 1968).
In some granules an apparently crystalline matrix 
has been reported. Fedorko & Hirsch (1965), from their 
electron microscopic study of the mast cells of human skin,
reported the presence of a honeycomb pattern in some granules, 
with a spacing of 12o£ between the parallel dense lines 
forming this substructure. Veinstock & Albright (1967) 
observed a similar substructure in human gingivial mast cell
granules. These authors described the substructure as a
highly ordered array of parallel, dense and less dense lines 
with a periodicity of 70^» or, if sectioned at 90° to this 
plane, a hexagonal latticed network with a centre-to-centre 
spacing of 7oX. A similar type of substructure has also been
observed in the granules of mast cells in patients suffering
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from uticaria pigmentosa (Kobayasi et al., 1968 ) • This type 
of ultrastructure, however, has yet to be demonstrated in rat
peritoneal mast cell granules,
Bloom & Haegermark (1965) during their studies of the
substructure of rat peritoneal mast cell granules following1
induced histamine release, observed some granules, in untreated
specimens, in which the electron density was consii erably
reduced, revealing a substructure composed of an extremely
fine filamentous meshwork in which electron dense particles 
of 75-100S were visualized. The number of granules of this 
type increased in frequency after histamine release.
Granules exhibiting this type of structure, although not
reported, can be observed in electron micrographs of mast cells 
from human bronchus (Brinkman, 1968), human skin (Kobayasi et 
al., 1968) and human gingiva (keinstock & Albright, 1967)* 
Examination of these granules by light microscopy reveals a
more intense metachromasia, in,lying that the filamentous 
network is composed of heparin (Bloom & Haegermark, 1965)*
This conclusion is supported by the observation of Archer 
(1961) that very little heparin is released from the mast 
cell granules during histamine release. Lloyd et a 1.. (1967)
also observed a network of fibres within mast cell granules.
Extraction of the mast cells with 2M-KC1 caused the dissolution
of this network, and a he. arin-protein complex was identified 
in this extract (Lloyd, Bloom & Balazs, 1967)•
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MATERIALS AND METHODS,
ISOLATION AND PURIFICATION (>F THE HEPARIN PROTEOGLYCAN OF OX
LIVER CAPSULE.
The capsule, stripped free from liver tissue, was
defatted in acetone, dried and powdered. Portions, 2Og each,
of this material were extracted in a blender with 400ral of a 
1# (w/v) solution of cetylpyridinium chloride in 2M-KC1 for 
lh. After centrifugation at 38OOOg av. for lh at 40C°, the 
clear supernatant was diluted to give a final concentration of
0.9M-KC1. The fine precipitate that gradually formed at 
room temperature during 4h was collected by filtration on a 
cellulose filter pad, the filtrate being discarded. The pad 
was eluted with 100ml of 2M-KC1, at 40C°, and the cetyl­
pyridinium ions dissociated from the complex and removed by 
shaking with 3 vol. of chloroform-pentan-l-ol (5t4 v/v)
(Scott, i960) at room temperature. The aqueous phase, when 
the cetylpyridinium chloride had been extensively eliminated, 
as verified by the disappearance of its characteristic E26O* 
was dialysed against glass-distilled water for 48h at 4°C. 
After stepwise addition of 4 vol. of ethanol at room temper­
ature, the solution was centrifuged at 38OOOg av. for lh.
Then 1 vol. of a saturated solution of potassium acetate in
ethanol was slowly added to the supernatant. The white
precipitate that then formed was collected by centrifugation,
washed in acetone and dried. The material was redissolved
in water and the ethanol fractionation repeated twice. The
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final dry powder was stored in a desiccator over until
required for analysis•
3L00D ANTICOAGULANT ASSAY.
The blood anticoagulant activity of the preparation 
was determined by the method of Jacques (19^3) as modified 
by Sharp, Excell, Salzman & Thorup (1961). This method 
involves the titration of the heparin preparation with
protamine and the comparison of its activity with that of a 
standard preparation (Doots Ltd*, crystalline, cresol-free).
ASH AND MOISTURE CONTENT.
The ash and moisture content of the preparation was 
determined by the method of Eastoe & Courts (1963)•
AMINO ACID ANALYSIS.
Samples of the preparation were hydrolysed for amino 
acid analysis in constant-boiling HCl (2ml/mg of material) 
under nitrogen, in sealed tubes at 110°C for 24, 36 and 7^h. 
Excess of acid was removed from the hydrolysates in a rotary 
film evaporator at 30°C. Owing to the presence of cyst(e)ine, 
separate portions of the material were oxidised with performic 
acid (Schram, Moore & Bigwood, 195^) before hydrolysis.
The amino acid analyses were carried out in triplicate with a
Technicon AutoAnalyzer. The reproducibility of the results 
was about - 1.5$» Superimposition of valine and glucosamine 
peaks was prevented by using an initial buffer of pH 2.75
and by replacing 10 and 7®1 of buffer in the first and second
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chambers of the Autograd with methanol.
HEXOSAMINE 1N1LYSXS.
The hydrolysis for hexosamine analysis was carried 
out in 4M-HC1 (2ml/mg of material) at 100°C for lOh (Volfrom, 
Veisblat, Karabinos, McNeely & McLean, 19^3) under nitrogen 
in sealed tubes. Excess of acid was neutralized and total
hexosamine was detorrained by the method of Cessi A Filiego 
(I960).
This procedure involves the distillation of the
volatile fraction of chromogens formed by heating amino sugars
with acetylacetone in an alkaline medium, thereby preventing
the interference of amino acids during colour production. 
Ogsten (1964), however, pointed out that the estimation of 
hexosamines in complex polysaccharides may give low results
because other substances present may be converted, during
hydrolysis, into products that subsequently decrease the 
yield of chromogen formed in the reaction with acetylacetone.
To check this source of error, Serafini-Fracassini, Peters A 
Floreani (1967) hydrolysed samples of bovine haemoglobin, 
ossein gelatin and serum albumin together with known
quantities of hexosamine under the conditions specified for *
hexosamine determination. The results of this investigation
showed that haemoglobin did not interfere even in 1000 fold
excess, gelatin lowered the yield if in 200 fold excess, and
albumin, in the range 200-2000 fold excess, had the opposite
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effect* None of the proteins tested caused any significant
interference in the range used in the present investigation.
The concentrations of glucosamine and galactosamine 
were determined after chromatographic separation (partridge 
& Elsden, 1961).
In all cases the values were corrected for losses
during hydrolyses.
HEXURONIC ACID ASSAY.
Quantitative determination of hexuronic acid was 
performed by the method of Bitter & Muir (1962). This method 
is a modification of the carbazole method of Dische (19^7)*
The use of borate in sulphuric acid is claimed to increase
sensitivity, increase the stability of the colour, which is 
developed immediately, and give greater reproducibility due
to reduced interference by chloride ions and oxidants.
XYLOSE ASSAY.
Xylose was determined by the anthrone method of 
Tsiganos & Muir (1966). This method gives good reproducibility 
and, due to differences in reactivity, xylose can be determined
in a mixture of pentoses. Furthermore, interference due to
hexo8es, hexuronic acids, hexosamine and protein is negligible.
SULPHUR ANALYSIS.
The method used for sulphate estimation was that 
described by Glellman A TOlg (i960). The principle employed
is the reduction of sulphate to hydrogen sulphide which is
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distilled, in a hydrogen atmosphere, into 2M-NaOH producing 
sodium sulphide. The sodium sulphide formed is then titrated
with cadmium solution, using dithizone as indicator.
IDENTIFICATION OF NEUTRAL SUGARS.
Samples of the complex were hydrolysed in 2M-HC1 
(2ml/mg of material) at 100°C for 8h. The identity of the 
neutral sugars present In the hydrolysate was determined by
thin layer chromatography on kieselguhr G by the method of 
Stahl & Kaltenbach (1961).
The solvent was composed of 65ml ethyl acetate and 
25111I of a mixture of isopropanol and distilled water (2tl, 
by volume). The plates were developed in a Desaga S-chamber 
(Desaga Co., Heidelberg, Germany) and stained with anisaldehyd 
in sulphuric acid.
ALKALI-INDUCED p-CAKBONYL ELIMINATION.
Among the methods available for demonstrating the
presence of O-glycosidic linkages to the hydroxyl groups of 
serine and threonine residues in proteins, ^-elimination is 
probably the most widely employed. If a glycoprotein contains 
such a linkage, then prolonged treatment with dilute alkali, 
followed by amino acid analysis, reveals a decreased
concentration in the particular amino acid involved.
Neuberger, Gottschalk & Marshall (1966) have reported 
a mechanism for this reaction, when serine is involved in 
O-glycosidic linkage. The masking of the amino and carbonyl
2h
groups of the amino acid, in proteins, increases the acidity
of the QC-hydrogen atom, thereby rendering it susceptible to
attack by alkali, as followsi-
OH ------- ►
CO
-- glycosyl.
i e ' t i d e --------
peptide
—► C - N I - peptide
peptide
dehydro-alanine
If this reaction is carried out in the presence of
Adams catalyst, under hydrogen, then amino acid ana lysis
reveals a loss in serine concentration and a corresponding
increase in alanine due to the reduction of dehydroalanine, 
p-elimination of O-substituted threonine occurs by a similar 
mechanism, but Adams (l9b5) has proposed that threonine
follows two separate pathways:-
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Glycosyl•
I
0 Process I
H - C - CH«
Glyc-O-CH=CH2
GH^CJIO -j- Gly-011
H
H - C0- CH - N'l —
CO
Process II
CH - CH^
- NH -
hydrolysis
co2n
co
NH2
N
i
peptide cleavage
hydrolysis
CIl^CHoC< CO-NH-CH.R -► CIUCHgCOCC 2H
After alkaline treatment, therefore, one would expect
the amino acid analysis to reveal a reduction in threonine
content and an increase in glycine content. If thi s
reaction is carried out in the presence of Adams catalyst,
under hydrogen, the intermediate formed in process II would be 
reduced, yielding ^-aminobutyric acid. Tanaka et al., (1964) 
have reported, however, that only 15’ of the threonine lost 
was recovered as£(-ai»inobutyric acid in material treated in 
this way, and Anderson et al., (1964) could account for only 
35 of the threonine lost asZXr^minobutyric acid. It would 
appear, therefore, th ■ t process I is also operative when
hydrogenation is applied, and, in the hydrolysate of material
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treated with dilute alkali, a reduced threonine content, an 
increased glycine content and a small amount of/^aminobutyric 
acid should be detected.
By subjecting a glycoprotein to alkali-induced p- 
elimination, both with and without hydrogenation, followed by
amino acid analysis, it is possible not only to demonstrate
the presence of an O-glycosidic linkage, but also to identify
the amino acid involved.
A 40mg sample of the material was dissolved in lOinl 
of 0.5 M-NaOH and stirred, under nitrogen, for 24h. The 
formation of the unsaturated derivative(a) of the hydroxy- 
amino acid(s) involved in the heparin proteoglycan linkage 
region was followed, by recording the change in absorbancy 
at 241 mu in a Beckman D.B. spectrophotometer (Riley, Turnbull 
& Wilson, 1957)* A. sample of bovine chondromucoprotein was 
subjected to identical treatment for comparison. A 5ml 
portion of this solution was then acidified to give a final 
concentration of 6M-HC1 and hydrolysed for 24h in sealed 
tubes, under nitrogen, at 110°C before amino acid analysis.
The remainder was neutralised and used for chromatography on 
AE cellulose (see below).
A separate 20mg sample was hydrogenated by the method 
of Anderson, Hoffman & Meyer (1965) with 20mg of Adams 
catalyst (Adams, Voorhees & Shiner, 19^1) in 5ml of 0.5 M- 
NaOH for 24h at room temperature. The catalyst was removed
by filtration and washed several times with small amounts of
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cone. HCl. The washings were added to the initial filtrate 
and, after adjustment of the HCl concentration to 6m, 30ml 
of constant-boiling HCl was added. The hydrolysis for amino 
acid analysis was carried out under reflux for 24h. The 
presence of^-aniinobutyric acid in the above hydrolysate was 
detected by two dimensional thin layer chromatography on 
silica gel G by the tnothod of Fahmy, Neiderweisser, Pataki & 
Bromner (1961) using chloroform1 methanol:17°> ammonium 
hydroxide (2:2:1, by volume) in the first direction and 
phenol:water (3:1» by weight) containing 20mg sodium cyanide 
per lOOg of mixture in the second. The chromatograms were 
developed in a Desaga S-chamber and stained with ninhydrin.
chromatograjhy on a.e. cellulose
The adsorbent, lm-equiv. of cationic groups per g 
(Whatman, W. and R. Ralston, Ltd., Maidstone, Kent), after 
repeated washing with 0.5M-HCl and 0.5M-Na0H, was suspended 
in O.lM-NaCl, degassed and poured into a 1cm glass column
to a height of 30cm. Water was passed through the column
and the effluent tested with silver nitrate for NaCl content
When a chloride-free effluent had been attained, the flow 
rate was adjusted to 12ml/h. After application of the 
sample, the column was washed with water for lh. Stepwise
elution was carried out with 50®l volumes of different NaCl
concentrations in 0.01M-HC1; O.25M increments in NaCl
concentrations were used. Fractions, 2ml each, were
collected and tested for polysaccharide content with a 1$
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(w/v) solution of cetylpyridinium chloride (scott, i960). 
Chondroitin sulphate (Lot no. 15B-0010, Sigma Chemical Co., 
St. Louis, Mo., V. .A.) and heparin (Lot no. 136651» Wilson 
Laboratories, Chicago, Ill., U.S.A*) were used as standards 
for the determination of their relative retention volumes.
COLUMN CHROMATOGKAPHY ON AGAROSE GEL
A column of agarose consists of two phases; a gel
phase of agarose granules and a liquid phase. If the
volume of the gel phase is Vx, the volume of the liquid phase
is Vo and the total bed volume is Vt, then Vt « Vo ♦ Vx.
Now if a substance, whose molecular weight is such that its
molecules cannot enter the gel, is applied to the column, 
then the molecules will permeate only the liquid phase (Vo) 
and will be eluted immediately after the void volume (Ve).
If, however, the molecular size is such that a certain volume
of the gel particles is accessible to them, then there will
tend to be an equilibrium of the molecules between the liquid
and gel phases. If K is that fraction of the gel accessible
to the molecules, then the volume of gel accessible to the
molecules is given by VxK. Therefore, the total volume
accessible to the molecules in the liquid phase and the
fraction of the gel phase is V c Vo + VxK
Whence K » V - Vo Ve - Vo
Vx “ Vt - Vo
Ve is tho elution volume
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Laurent & Killander (1964) have shown that the radius 
of gyration of the molecules can be directly related to K by 
the equation
K =a exp. ^TT L (ra ♦ rr)2_7 
where L is the concentration of the macromolecules
constituting the supporting network in the gel solution, rs 
is the Stokes radius of the molecule, and r is the radius 
of gyration of the macromolecular rods. Thus, by calibrating 
a column using proteins of known Stokes radius, it is possible 
to estimate the Stokes radius of any other molecule after 
determining its K value.
Bio-Gel A-15® containing 4$ agarose (Bio-Rad 
Laboratories, Richmond, California, U.S.A., Lot no. 6197•
Mesh 100-200) was degassed and packed into a 1.5cm diameter 
glass column to a height of 90cm. This agarose gel is 
supplied as a suspension containing 0.02'/> azide. After 
packing lM-potasslum acetate pH 7*0 was passed through the
column until no more azide could be detected by spectrophoto­
metry. The potassium acetate was allowed to pass through 
the column for a further 24h to ensure complete equilibration 
and the flow rate adjusted to 6ml/h. lM-potassium acetate 
pH 7*0 containing 0.02% (w/v) was flushed through the system 
after each separation to prevent bacterial degradation.
The total bed volume of the agarose was estimated by
filling the column to a height of 90cm with water and
measuring the volume required. The void volume was determined
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by applying a suspension of narcissus mosiac virus to the column. 
The size of this virus is such that it is totally excluded 
from the gel particles. The volume of effluent collected
f
TABLE 1. Summary of agarose column characterization
PROTEIN0 Kav STOKES RADIUS rsX
Horse radish peroxidase 0.853 30.2
Bovine thyroglobulin 0.546 81.0+
Glutamic dehydrogenase 0.657 64.o+
Yeast alcohol
dehydrogenase
0.783 45.5+
Laurent & Killander (1964)
Rogers & Thompson (1963) +
0 All proteins supplied by Sigma Chemical Co., St. Louis, Mo., U.S.A. 
Fig. 1. Plot*of Kav against Stokes radius
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before the virus was excluded from the column, determined by 
spectrophotometry, was taken to be the void volume of the 
column. The column was characterized by determining the
elution volumes of four proteins of known Stokes radius,
namely horse radish peroxidase, bovine thyroglobulin, glutamic 
dehydrogenase and yeast alcohol dehydrogenase. Each protein 
was dissolved in lM-potassium acetate and passed through the 
column separately. 3ml fractions of effluent were collected 
and each tube was read at 278 mu in a spectrophotometer.
The results of this analysis is summarised in Table 1, and 
a plot of Kav against Stokes radius in X units is shown in 
Fig. 1.
Samples, lOmg each of heparin proteoglycan were 
dissolved in 2ml lM-potassium acetate pH 7*0 and applied to 
the column. The flow rate had previously been adjusted to 
12ml/h and the fractions, 3ml each, were analysed for uronic 
acid content by the method of Bitter & Muir (1962).
TREATMENT OF HEPARIN PROTEOGLYCAN ■ TTN RLRC APTCETHANOL
20mg of dried purified complex was dissolved in 2ml 
distilled water and adjusted to pH 8.0 with O.lM-NaOH.
1.5^g of 2-mercaptoethanol was added and the volume was made 
up to 20ml and the pH readjusted. The reaction was allowed to 
continue at room temperature for 24h under nitrogen.
Iodoacetamide equivalent to twice the amount of mercaptoethanol
was then added to the reactants and the mixture was shaken for
a further 4h This process was repeated until all the
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mercaptoethanol had reacted, verified by the loss of its
characteristic odour. The reaction mixture was then dialysed 
for 24h at 4°C against distilled water, during which time a 
white suspension formed. This suspension also formed when
mercaptoethanol and iodoacetamide were reacted in water, but
was found to be soluble in ethanol. The mercaptoethanol
treated material was precipitated from solution by the
addition of 4 vol. of ethanol and 1 vol. of ethanol saturated
with potassium acetate. After the material had been dried,
it was redissolved in 2ml lM-potassium acetate and subjected
to column chromatography on agarose
ACRYLAMIDE GEL ELECTROPHORESIS.
Acrylamide gel electrophoresis was performed by the 
gel slab method of Raymond & Veintraub (1959) as described 
by Tombs (1965)•
15g of "Cyanogum 41” was dissolved in 100ml of distilled 
water, and filtered to remove any undissolved particles. 0.5ml
of 2-dimethylaminopropionitrile followed by 1.0ml of a freshly 
prepared lO'/o (w/v) ammonium persulphate solution were then 
mixed into the clarified "Cyanogum 4l” solution. This mixture 
was poured into a perspex casting tray (8 x l6cni and 2mm deep) 
containing four perspex spacers, (10 x 0.5 and 2mrn high) placed 
3cm from one end of the tray. These spacers form tho starting
slots of the gel. After removal of all air bubbles from the
tray, a glass plate was placed on top so that a little of the
gel mixture was excluded This procedure ensured the air-
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tight seal essential for gellation. After the gel formed, 
it adhered to the glass plate, from which it was carefully 
removed and allowed to dialyse against buffer for 24h.
The gels were run in the discontinuous system of 
0.05M-Tris citrate pH 8.6 inside the gel and 0•05M-sodiura 
borate pH 8.6 in the tank. Experiments were carried out with 
the gels in perspex supporting trays, of the same dimensions
as the casting trays but containing no perspex spacer, in a
Shandon Universal Electrophoresis Apparatus. This buffer 
system produces a brown line in the gels, marking the inter­
face of the two buffers, which allows each gel to be terminated 
at the same point.
Samples of the proteoglycan and heparin (Wilson 
Laboratories, Chicago, Ill, U.S.A.) were dissolved in 0.05M- 
tris citrate buffer pH 8.6 and placed in the starting slots 
of the gels. Double paper wicks of Vhatmann 3MM paper were 
used to connect the gels to the tank and a voltage of 350v 
applied. The gels were run without cooling until the brown
line reached the marker in the running tray, and were then
removed and stained with amido black or toluidine blue.
The amido black stain was composed of methanol:water: 
glyceroltacetic acid (50:50:20:1, by volume) saturated with 
amido black. The gels were allowed to stain for 20min in
this mixture and wore destained in 1> acetic acid overnight.
The toluidine blue stain was composed of methanol:water: 
glycerol: (50:50:20, by volume) saturated with toluidine blue.
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The gels were stained for 20min and destained with distilled
water. The methanol used in the above staining mixtures
fixes the samples in the gels, but the use of methanol alone 
would cause marked shrinkage and cracking. The glycerol in
the mixture mediates the effects of the alcohol and prevents
these side effects. After destaining, the gels were stored
in polythene bags.
The acrylamide gel slab method was used in preference 
to the disc method (Ornstein & Davis, 1964) because, although 
slower, the former method allows exact comparison of samples 
since they are travelling through an identical gel at an 
identical voltage for an identical time.
AMINO BNP-GROUI ANALYSIS
The 2-chloro-J,5-dinitropyridine method (signor et 
al., 1964) was used since this procedure has the advantage
over the 2,4-dinitrofluorobenzene method that the glycine 
derivative is stable to acid hydrolysis.
A 20mg sample of the heparin proteoglycan was
dissolved in water in the reaction vessel of a Radiometer
pH-stat set at pH 9*0. At this pH the only amino acid which 
will not react with the reagent is tryptophan. The micro­
syringe was filled with 0.25M-Na0H and nitrogen was bubbled 
through the solution. After the pH had been stabilised, 6ml 
of ethanol containing 6.1mg of 2-chloro-3,5-dinitropyridine 
was added and the reaction was allowed to proceed for 5b at
room temperature. When the reaction was complete, the solution
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was acidified to pH 2.0 with HCl and excess reagent and 2- 
hydroxy-3,5-dinitropyridine were removed by exhaustive 
extraction with ethyl acetate. The dinitropyridyl materials 
were then precipitated by the addition of 4 volumes of ethanol 
and one volume of ethanol saturated with potassium acetate.
The precipitate was washed several times with ethanol and
dried in a vacuum desiccator. This material was then
hydrolysed, after weighing, with 20ml of constant-boiling 
HCl in sealed tubes under nitrogen at 60°C for 10h. The 
hydrolysate was adjusted to pH 2.0 with KOH and the liberated 
dinitropyridyl amino acids were extracted with 6 portions 
(10ml each) of ethyl acetate. The pooled ethyl acetate 
extracts were twice washed with 5ml 0.01M-HC1. The water
phase together with the acid washings of the ethyl acetate
extracts were taken to dryness and the residue was dissolved 
in constant-boiling HCl and subjected to hydrolysis for 24h 
at 110°C in sealed tubes under nitrogen prior to amino acid 
analysis. The identity and concentration of the amino end-
group amino acids was established by comparison with the
amino acid analysis of untreated material.
ULTRACENTRIFUGATIOH
To evaluate the homogeneity of the heparin proteoglycan 
it was dissolved in O.lM-sodium phosphate buffer pH 7*0» 
containing 0.4M-NaCl. The material was exhaustively dialysed 
against this buffer system and submitted to analytical ultra­
centrifugation at 597&O rev./min. Its concentration was
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determined in a refractometer•
OSMOMETRY
The instrument used was a 501 high-speed standard 
membrane osmometer (Hewlett-Packard, Pa*, U.S.A.) equipped 
with B-l nienbranes (Schleicher & Schnell, Keene, Germany).
A temperature of 25°C was maintained throughout the experiment.
All measurements of osmotic pressure were made with
a high concentration of diffusible electrolyte to blank out 
any effect duo to counter-ions. The sample was exhaustively
dialysed against lM-potassium acetate buffer pH 7«0» and, 
after dialysis, the protein-polysaccharide concentrations 
were determined using a differential refractometer (Bendix 
Electronics, Nottingham) using the 5^6 mu mercury line. No 
loss of material was detected during dialysis.
A series of progressive dilutions of the sample was
prepared and four determinations of osmotic pressure were 
made for each sample concentration, A graph of /\/C as a 
function of C (where C = concentration and / \ = osmotic 
pressure) was plotted.
ELECTRON MICROSCOPY
HEPARIN PRCTEOGLYC AN .
The heparin proteoglycan was isolated as previously
described. The white precipitate which formed during the
first precipitation with alcohol and potassium acetate was
collected by centrifugation and dried in acetone. A sample
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of this precipitate (sample l) was submitted to electron 
microscopic analysis. When this material was resuspended in 
water, 40^ remained insoluble. The soluble fraction was 
twice subjected to alcohol precipitation and a sample of the 
final dry powder (sample 2) was dissolved in water for 
examination in the electron microscope.
The aqueous solutions of samples 1 and 2 were 
exhaustively dialysed against distilled water and sprayed at 
a concentration of approximately 3ug/ml on to carbon-coated 
grids. The monolayers of the heparin-protein complex were 
then stained for lOmin in 0.5^ bismuth nitrate in O.lM-nitric 
acid (Serafini-Fracassini & Smith, 1966).
MAST CELLS.
Rat peritoneal fluid was collected using a 
modification of the method described by Uvn&s & Thon (1959).
The rats were decapitated and exsanguinated. Six ml of phenol 
red-free Hank’s solution were then injected into the peritoneal
cavity and, after the abdomen had been gently massaged for
90sec, the peritoneal fluid was removed, great care being
taken to ensure that no blood was allowed to enter the
peritoneal cavity, if contamination, due to leakage of
blood, was observed the samples were discarded. The isolated 
peritoneal fluid was centrifuged for lOmin at 450g, and the 
cell pellet was washed with phenol red-free Hank’s solution,
fixed in 1> osmium tetroxide in veronal-acetate buffer pH 7*2
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and embedded in Araldite. Ultrathin sections were cut with
glass knives on a LKB-111 ultra-microtome and stained with 
bismuth nitrate or uranyl acetate. In trial experiments 
gluteraldehyde was used but was found to impair the bismuth
s taining.
BISMUTH STAIN
The bismuth stain was prepared by the method of 
Serafini-Fracassini & Smith (1966).
lg bismuth nitrate was dissolved in 10ml 2M-nitric 
acid and this was made up to a final volume of 200inl with
distilled water. Since there is a tendency for the bismuth
nitrate to precipitate during dilution, the water was allowed 
to drip slowly into solution from a burette while the bismuth 
nitrate in nitric acid solution was agitated with a magnetic 
stirrer. This procedure gives a 0.5$ solution of bismuth 
nitrate in O.lM-nitric acid pH 1.2. Staining times of lOmin
were used.
URANYL ACETATE STA.IN
Grids were stained in 2% uranyl acetate (w/v) for
20niins •
STAINING PROCEDURE
Grids were stained by flotation on the surface of the
stains in staining dishes. After the required time had
elapsed, the staining dishes were filled with water and the
grids were washed for 30mins. This washing procedure was
carried out several times
39
RESULTS
ISOLATION PROCEDURE
The material, after the initial ethanol fractionation,
was dried in acetone and stored in a desiccator, When a
sufficient quantity for analysis had been collected, the
pooled material was redissolved in water and resubmitted to
ethanol fractionation. It was found that 40n of this first
preparation remained insoluble after 12h stirring. This
insoluble fraction was found to have a sulphur content of only
O.25r • The soluble fraction, however, once precipitated and
dried, gave a preparation that was readily soluble. Its yield
averaged 35mg of protein-p dysaccharide per lOOg of dry ox
liver capsule. This is the fraction that was subjected to
chemical and biological analysis.
BIOLOGIC\L \CTI VITY
The anticoagulant activity of the preparation averaged 
55 B.P. units/mg.
PROTEIN CONTENT VN1> VHJNC ACID COMPOSITION OF Hl? PROTEO­
GLYCAN OF HCPARIN
To determine the protein content of the heparin
proteoglycan and individual amino acid recoveries after acid
hydrolysis, a sample of the material was analysed after
hydrolysis for 24, 36 and 72h at 110°C.
The results of amino acid analysis are reported in
Table 2, column (a), where the concentrations are expressed as 
ug of anhydro amino acid/lOmg of dry and ash-free material.
4o
The corrected concentrations of the various amino acids were
calculated by either selecting the greatest value for those 
showing increased concentration during hydrolysis or by
extrapolating to zero hydrolysis time those values showing
linear kinetics of hydrolytic destruction. In the case of
serine and threonine all three values gave a linear relation­
ship, but since non-linear behaviour was observed for proline, 
tyrosine and arginine + ornithine only the 24 and 36h values 
were extrapolated to zero hydrolysis time. In Table 2, 
column (B), the corrected amino acid composition of the protein 
component is reported, whereas column (c) shows the percentage 
zero time recovery for each amino acid after 24h hydrolysis.
A protein content of 13.21'/ was derived by summation of the
corrected values.
ANALYSIS OF THJ CARBOHYDRATE MOIETY
The results of analysis for hexosamine content are
reported in Table 3* A glucosamine to galactosamine ratio
of 26.4 to 1 was obtained.
The total hexuronic acid conteut is reported in Table
3» expressed both as free acid and potassium salt.
The quantitative determination of xylose showed that
more than one chromogen was formed during the reaction of the
anthrone and the heparin proteoglycan. The main one had an 
absorption maximum at 6l5mu, but at least another two were 
present, with absorption maxima at $60 and The optical
density was read at 6l3mu and the xylose content is reported
in Table 3.
Thin-layer chromatography for neutral sugars revealed 
only two spots, after staining with anisaldehyd© in sulphuric 
acid. These spots produced the colours and Rf values expected 
of xylose and galactose. These were the only neutral sugars
present in the hydrolysates.
The sulphur ontent, determined by the method of 
Giellman & Tftig (i960), is reported in Table 3» where it is 
expressed as free sulphur and ester sulphate, potassium salt.
ALKALI-INDUCED p-ELIMINATIQM
The occurrence of p-carbonyl elimination in a sample 
of heparin proteoglycan was demonstrated by recording, over 
24h, the change in absorbance of the preparation of 24lmu, 
when dissolved in 0.5M-NaOH (Fig. 2a). A sample of bovine 
chondro-mucoprotein was subjected to Identical treatment and 
its reaction plot is reported for comparison (Fig. 2b).
The amino acid compositions of the two samples 
subjected to alkaline treatment either with or without 
catalytic hydrogenation are shown in Table 4, where they are 
compared with the corresponding hydrolysate of untreated 
material. It can be seen that p-elimination, both with and 
without hydrogenation, results in a reduction in the threonine 
concentration, by 19*1 and 33*8$> respectively, while the 
serine content is only very slightly affected. Furthermore
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after alkaline treatment in the presence of Adams catalyst,
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TABLE 2. Amino acid, analysis of heparin proteoglycan
j -
L
(J) Wt. of anhydro amino acid (/xg./lOmg. of heparin-protein complex, ash- and moisture-free); (li) wt. of 
anhydro amino acid (g./lOOg. of the protein component); (C) recovery after 24 hr. hydrolysis (%).
Time of hydrolysis
(hr.) ............
Amino acid
24
M)
 -A--- - -
(B)
t
Corrected
values
Corrected
values (C)36 72
Cysteic acid 623 60-4 67-3 63-3* 4-79 98-3
Hydroxyproline 1-5 Trace Trace l-5f 0-11 100-0
Aspartic acid 128-8 128-6 128-6 128-8f 9-75 100-0
Threonine 64-9 61-8 51-6 71-7J 5-43 90-5
Serine 53-9 490 33-5 64-3J 4-87 83-8
Glutamic acid 183-5 190-3 191-2 191-2f 14-48 96-0
Proline 80-9 76-5 75-9 89-7§ 6-79 90-2
Glycine 83-7 85-8 88-3 88-3f 6-69 94-8
Alanine 73-9 75-2 800 80-0f 606 92-4
Valine 66-6 68-6 68-8 68-8f 5-21 96-8
Methionine 00 0-0 00 0-0 0-00
Isoleucine 40-6 42-2 42-7 42-7f 3 23 95-1
Leucine 105-7 109-5 109-3 109-5f 8-29 96-5
Tyrosine 6 3 4-2 4-6 10-5§ 0-79 60-0
Phenylalanine 69-5 70-7 68-6 7O-7f 5-35 98-4
Hydroxylysine 0-0 00 0-0 0-0 000
Ornithine
Lysine
5-1
111-0
51
112-2
6-2
112-2 112-2f 8-49 98-9
Histidine 31-2 31-3 28-7 31-3f 2-37 99-7
Arginine
Arginine + ornithine
90-3
(95-4)
89-9
(95-0)
82-0
(88-2) 96-3§
7-29
99-1
Totals 1259-7 1261-3 1239-5 1320-8 99-99
* Average value (24hr., 36hr. and 72hr. hydrolysates).
t Greatest value.
J Extrapolation to zero time (24hr., 36hr. and 72hr. hydrolysates). 
§ Extrapolation to zero time (24hr. and 36hr. hydrolysates).
TABLE 3. Composition of heparin proteoglycan
Values are expressed as percentages of dry ash-free 
material.
Protein 13-21
Total hexosamine (as free base) 14-82
Glucosamine 14-28
Galacto8amine 0-54
Hexuronic acid (as free acid) 27-83
Hexuronic acid (as potassium salt) 33-39
Xylose 0-68
Sulphur (as S) 8-90
Sulphur (as ester sulphate, potas­ 33-09
sium salt)
Total 95-19
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the glycine content is reduced by only 12.9^» whereas the 
reduction in the concentrations of alanine, leucine, iso­
leucine and valine averages 28.0>,, These figures are
interpreted as reflecting an increase in glycine content.
Owing to the superimposition of glucosamine and 
^-aminobutyric acid paks, precise identification of the latter
in hydrolysates of the material subjected to p-elimination 
and hydrogenation proved unfeasible by automatic amino acid
analysis, although the marked asymmetry of the glucosamine
peak implied its presence. However, when two-dimensional
thin layer chromatography for amino acids was applied to 
this hydrolysate an extra spot in the pattern was observed.
The material contained in this spot was found to co-chromato­
graph with a standard of <Xj-awinobutyric acid. Thus, the 
presence of <X-amino butyric acid in the hydrolysates of 
heparin proteoglycan subjected to p-ellminatlon and hydro­
genation was conclusively demonstrated.
COLUMN CHHOMATOGRAPHY ON AE-CELLULOSE
Column chromatography of commercial heparin and
chondroitin sulphate was performed on AE-cellulose as
described in the Materials and Methods section. Chondroitin
sulphate and heparin were eluted by l.OM-and l.^M-sodium
chloride respectively. In this system, however, concentrat­
ions of sodium chloride in excess of 3M failed to displace any 
fraction of the untreated material. After p-elimination,
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2. p-elimination
10 15
TIME (HOURS)
Fig- 2. .
Assay a: 360mg/ml heparin proteoglycan in O.JM-HaOH compared to an 
aqueous solution of identical concentration as blank.
Assay bs 540mg/ml chondroitin sulphate proteoglycan in O.^-NaOH
compared to an aqueous solution of identical concentration 
as blank.
The absorbancy at 241mu was recorded with a Beckman D.B. 
recording spectrophotometer.
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however, the polysaccharide was eluted "by 1.5M-sodium chloride.
ULTRACENTRIFUGATION
To evaluate the homogeniety of the preparation, it was dissolved 
in O.lM-sodium phosphate buffer pH 7.0, containing 0.4M—NaCl, and 
submitted to analytical ultracentrifugation at 59780 rev./min. In 
this system the material behaved as a single peak characterised by 
a sedimentation coefficient of I.85S. (Fig. 3.).
TABLE 4« Amino acid analysis of heparin proteoglycan after B-elimination
Values arc reported aH wt. of anhydro amino acid 
10 mg. of dry ash-free protein-polysaccharide complex). All 
hydrolyses were carried out for 24 hr. (A) Untreated sample; 
(B) sample after ^-elimination; ((') sample after ^-elimin­
ation and reduction in the presence of Adams catalyst. 
N.D., Not determined.
Amino acid
M) (B) (O
Cysteic acid 62-3 N.D. N.D.
Hydroxyprolinc 1-5 0-0 0-0
Aspartic acid 128-8 120-4 89-3
Threonine 64-9 52-5 43-0
Serine 53-9 52-6 50-8
Glutamic acid 183-5 182-7 148-2
Proline 80-9 80-5 62-3
Glycine 83-7 83-8 72-9
Alanine 73-9 76-1 57-0
Valine 66-6 64-3 471
Methionine 0-0 0-0 0-0
Isoleucine 40-6 37-7 29-1
Leucine 105-7 99-9 72-4
Tyrosine 6-3 32-7 35-2
Phenylalanine 69-5 65-6 45-1
Hydroxylysinc 0-0 0-0 0-0
Ornithine 5-1 90 15-3
Lysine 111-0 105-5 72-1
Histidine 31-2 26-6 24-9
Arginine 90-3 86-7 57-3
Arginine + ornithine (95-4) (95-7) (72-6)
Fig. 3. Ultracentrifugal pattern of heparin proteoglycan.
Its total concentration was 0.945% (w/v;. The 
picture was taken at a schlieren angle of 60° at 
80 min after the rotor had reached a nominal speed 
of 59780 rev./min. The direction of sedimentation 
is from left to right.
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COLUMN CHROMATOGRAPHY ON AGAROSE--- .--- - --------- ---- -
Column chromatography of the heparin proteoglycan
was carried out in lM-potassium acetate pH 7*0 1** a pre- 
calibrated Bio-Gel A-15*n column (See Materials and Methods).
The elution pattern of material subjected to this 
process is shown in Fig. 4. The column effluent was monitored
for hexuronic acid content, and from these values the amount
of heparin proteoglycan present in each fraction was
calculated, together with the total recovery of material from
the column. Four fractions were recovered characterised by 
elution volumes of 48, 58, 93 and 117 ml respectively, 
containing 2, 3» 15» and 80% of the recovered sample. The 
percentage recovery of the heparin proteoglycan averaged 98;-.
throughout. Dy substituting the above elutlLon volumes into 
tho standard equation, Kav for each fraction, except the first, 
(which was excluded) can be calcxilated and, from the standard 
graph of Kav against Stokes radius, an approximate value of 
Stokes radius for'each fraction is obtained. In the case of 
the heparin proteoglycan the fractions F II, III and IV, are 
characterized by Stokes radii of approx. 179&» and 32.5$
respectively.
It can be seen from the elution pattern that the 
greatest part of the material is contained in F IV. This 
fraction was collected, precipitated with ethanol, dried in 
acetone and stored in a desiccator for further analysis.
In view of the appreciable cystine or cysteine content 
of the original material, it was decided to subject a sample 
to treatment with 2-mercaptoethanol, in the hope of resolving 
the role of possible disulphide bridges in the macromolecules•
After 24h treatment wi ch 2-mercaptoethanol and 
subsequent blocking of the reduced thiol groups with iodo­
acetamide, the•elution pattern of a sample subjected to 
column chromatography on Bio-Gel A-15m remained identical to 
that observed for untreated samples (Fig. 4). A sample of 
pooled F I and F II from previous analyses was also treated 
in the above manner. The elution pattern of this material
revealed that in addition to unaffected F I and F II a small
^7.
amount of F III and F IV was also present
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The separation pattern of the heparin proteoglycan 
was examined over a wide pH range in 7 • 5^> polyacrylamide gels* 
The pattern (Fig. 5) was very similar to the elution diagram 
obtained from separation on agarose, The majority of the
material migrated as a single peak close to the solvent front,
although a certain degree of polydispersity was apparent. A
portion of material \\hich failed to move into the gel can be
seen at the origin slots. This fraction is probably of around
the same dimensions as F I and F II obtained from agarose
chromatography, When the gels were stained uith toluidine
blue, the entire electrophoretic pattern showed intense
metachromasia, but no orthochromatic bands were observed. On
the other hand, in gels stained with etrnido blick, there was no
evidence for the presence of free protein.
AMINO ACID COM) 0 1TION OF H'CPARIN ,PRbTt OG1.YCAN FRACTION F IV
Tho results of amino acid analysis of a 24h hydroly­
sate of the heparin proteoglyc n fraction F IV, obtained by 
chromatography on agarose, is reported in Table 5» column (b), 
whore the concentrations are expressed as ug of amino acid 
anhydro amino acid/10 mg of dry and ash-free material.
Column (a) reports the 24h hydrolysis values for the total 
extract (See Ttble 2). A protein content of 13.36”, was
\CRYLAMIDj; GEL ULhCTROPHORESIS OF HEPARIN PROTEOGLYCAN
derived for F IV from'the corrected amino acid v lues
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Fig. 4* Elution pattern of heparin proteoglycan on agarose
Fig. 4. Column: 90cm x l.^cm, Bio—Gel A—15m. Solvent: Ufi.—potassium 
acetate pH 7.0. The effluent was analysed, for hexuronic 
acid content by the method of Bitter & Muir (1962).
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Fig. 5. Electrophoretic pattern of the heparin proteoglycan
Fig. 5» 7 -5% .acrylamide gel. Tris-citrate/sodium "borate discontinuous
buffer pH 8.6. Stains toluidine blue. Central slots: 
heparin proteoglycan. Outer slots: heparin (Wilson Laboratories)
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fraction F IV.
(a) (B) wt of anhydro amino acid after 24h hydrolysis
(ug/lOmg of ash-and moisture-free material). (A) heparin
proteoglycan (B) fraction F IV (c) wt of anhydro amino acid
after 24h hydrolysis following treatment with 2-chloro-3•5-
dinitropyridine (ug/lOmg of ash-and moisture-free material)•
Amino acid  (U   (B) .... (c)........ .
Cysteic acid 62.3 . 57.5 57.7
Hydroxyproline 1.5 1.7 ....1.5
Aspartic acid 123.8 128.8 106.8
Threonine 64.9 64.2 .... 57.2 ....
Serine .33.9 37.9  58.5 . 
Glutamic Acid 183.5 185.1 171.5
Proline 8O.9 ...... 80.5 80.1
Glycine 83.7 124.2 123.6
Alanine 73.9 ........ 7 3. A . 73.4
Valine 66.6 67.0 66.5
Methionine 0.0 0.0 0.0
Isoleucine 4o,6 40.9 J9.6 
Leucine 105.7 91.2 76.1.... .
Tyrosine 6.3 30.0 8.4
Phenylalanine . 69.5 69.3 . 57.5
Hydroxylysine 0.0 0.0 0.0
Ornithine 5.1 6.0 15.6
Lysine 111.0 90.9 61.1
Histidine 31.2 17.9 17.2
Arginine .. 90.3 89.8 79,5 1
Arginine 4- Ornithine .. 23A.. 95.8 95.1
TOTAL. 1259.7 1274.3
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VNALY5IS OF CARBOHYDRATE MOI^fY OF HEPARIN PROTEOGLYCAN
FRACTION F IV
The results of quantitative analysis for hexosamine, 
hexuronic acid, xylose and sulphur are reported in Table 6.
During the reaction of the heparin proteoglycan with
anthrone to determine the xylose content, only one chromogen 
was formed, with a peak at 615 nu.
If it is assumed that heparin is joined to protein
only through linkages involving xylose, then that weight of 
heparin which contains 1 mole of xylose will be the molecular 
weight of the heparin chains. A molecular weight of 11300 
is obtained in this way for the heparin chains, based on a 
xylose content of 1.08' for the heparin proteoglycan.
Table 6 Chemical analysis of heparin proteglycan fraction
F IV
Values are expressed as percentages of dry-and
free material*
Protein
Total hexosamine (as free base)
Hexuronic acid (as free acid) 26*67
Hexuronic acid (as potassium salt)
Xylose
Sulphur (as S) 8.90
Sulphur (as ester sulphate, potassium 
salt)
TOTAL
ash-
13.36
15.42
32.00
1.08
33.09
94.95
5^
AMINO-END GROUP ANALYSIS OF HEPARIN PROTEOGLYCAN FRACTION F IV
A sample (2Cmg) of the heparin proteoglycan, after 
treatment with 2-chloro-3,5-dinitropyridine was hydrolysed in 
constant-boiling HCl at 6C°C for lOh. This hydrolysate was 
exhaustively washed with ethyl acetate to remove the liberated
dinitropyridyl-ainino acids. The ethyl acetate extracts were
washed with dilute acid, and the washings together with the
original hydrolysate were further hydrolysed in constant- 
boiling HCl at 110°C for 24h. The amino acid analysis of the 
resultant hydrolysate is reported in Table 5» column (c), 
where it is compared with a 24h hydrolysate of untreated 
material (Column B) . By this method the N-ter;riinal amino acids 
were identified, and their concentrations determined. Table
7, shows the four N-terrain.l amino acids togother with their
concentrations which are expressed as moles of amino acid per 
10K>g of protein-polysaccharide.
The number average molecular weight of a protein is
that weight which contains one ".ole of '-terminal amino acid.
By this method a molecular weight for the protein-poly-
saccharide of 19500 was obtained.
The ethyl acetate extracted dinitropyridyl amino acids
were not subjected to thin layer chromatography, since, in
view of the low concentration and tendency for the production
of artifacts during chromatogram development, it was
considered that the amino acid difference method was a great
deal more reliable
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MOLECULAR WEIGHT >ET; RMlNAi'ION BY OSHOM .TRY OF HEPARIN
PROTEOGLYCAN FRACTION F IV
The osmotic pressure determinations of F IV was
carried out at two concentrations of added HCl in order to
check if the contribution of the Donnan distribution of
mobile ions was affecting the observed values. The plot of 
the reduced osmotic pressures (71/C) as a function of solute 
concentrations (c) is reported in Fig. 6. Because no 
obvious curvature was detectable correction for non-ideality 
was performed by linear extrapolation of7T/C against C values 
to C = 0 by the method of least squares. The results were
then fitted to the standard equation.
RT
Mn = ----------
(^/c)c_^0
Where RT was corrected to account for the density
of the solvent. A derived number average molecular weight
of 20600 was obtained.
A summary of the molecular weight of the heparin
proteoglycan determined by osmometry and N-terminal analysis
together with the molecular weight of the heparin chain
derived from its xylose content is reported in Table 8.
TABLE 7. End-group analysis.
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Values are expressed as
protein-polysaccharide
Aspartic acid
Glutamic acid
Leucine
Phenylalanine
moles of amino acid/10^g of
19.6
10.5
13.3
8.0
TOTAL 51.4.
TADLr 8.
Method
Osmomo try
N-terminal Analysis
Molecular Weights
Component Molecular weight
heparin proteoglycan 20600
heparin proteoglycan 19500
Xylose content heparin chain 11300
57.
Fig. 6. Plot of .reduced osmotic pressure against concentration 
for the heparin proteoglycan
1.10-
~r-------------- r-
1 2 3 • 4 5 C
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ELECTRON MICROsSCOPY
HETARIN PROT .OGLYCAN
The electron microscopic appearance of the heparin
proteoglycan collected after the first alcohol precipitation 
(Sample l) is shown in Plate 1. Some of the material appears 
as filaments, although it is evident that these filaments
represent only a proportion of the total sample, the greater
part consisting of short segments or single particles which in
some areas have joined together to form structureless
aggregates•
When these filaments are examined at a higher 
magnification (Plate 2), it is evident that they are composed 
of particles. The average diameter of these particles when 
arranged in filaments (arrows a, Plate 2) is 35?* In 
certain restricted areas, however, the filaments tend to 
become entangled (arrows b, Plate 2) and the particle diameter 
averages 50?• By analogy with the results of an investigation 
of the morphology of the isolated protein-polysaccharide
complex of bovine nasal septum using bismuth nitrate stain 
(Serafini-Fracassini & Smith, 1966), the 35X particles are 
interpretated as single heparin chains which have adopted a
coiled cofiguration due to the neutralization of the charges
on the sulphate groups by bismuth ions. The larger particles
which are formed when the filaments become entangled are
probably due to the cross-linking and coiling together of
Under these conditions,several adjacent heparin chains
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conditions, therefore, there is no relationship between particle
diameter and molecular weight.
The appearance of the final soluble preparation 
(Sample 2), is shown in Plate 3. Particles exhibiting .
considerable variation in diameter are present. However, 
particles of 35$ average diameter are evident, either isolated 
or arranged as short rows (arrows a). It should be pointed I 
out that the filaments observed in Sample 1 were never found
in specimens of the highly purified material.
MIST CELL GRANULES.
UHVNYL ACETATE <T\INLD Mi^T CELL GRANULES.
The electron microscopic appearance of a typical
mast cell granule stained with uranyl acetate is shown in Plate 
4. It exhibits a uniform particulate appearance, but due to 
its electron density none of its detailed substructure can be 
observed. The compound granule (Plate 5) exhibits, for the 
greater part, an identical appearance. However, one region
of its matrix appears to be more heavily stained, giving the
impression of a more compact nature.
The disrupted granule shown in Plate 6 is also stained 
with uranyl acetate. A proportion of the granules contents seems
to have been lost revealing a network of electron dense "bodies"
Plate 1
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Plate 1
Monolayer of heparin proteoglycan macromolecules sprayed on 
to the grid after the first alcohol precipitation (Sample l) 
and stained with 0.5^ bismuth nitrate in nitric acid, pH 1.2. 
x 177500.
Plate 2
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Plate 2
Monolayer of heparin proteoglycan macromolecules sprayed, on
to the grid after the first alcohol precipitation (Sample l).
oArrow a indicates a typical headed filament composed of 35-A 
particles. Areas of entanglement are evident (arrows h).
The stain is 0.5^ bismuth nitrate in nitric acid, pH 1.2 
x 34OOOO.
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Plate 3
Plate 3
Monolayer of heparin proteoglycan macromolecule.s after repeated
alcohol fractionation (Sample 2). Arrow a points to a short
o ,
headed segment composed of 35~A particles. The stain is 0.5^
bismuth nitrate in nitric acid, pH 1.2. x 520000
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connected by material which is less heavily stained.
Uranyl acetate is a non-specific stain when used at 
neutral pH. At pH 7*0» it would be expected that the uranium 
ions would react, not only with the strongly acidic groups 
of any heparin, but also with the many protein components 
known to be present in the mast cell granules. Although 
examination of a disrupted granule produces some improvement
in the resolution of the substructure of the granule, it
remains impossible to make any meaningful deductions.
BISMUTH NITRVr SlhlNIN'r.
The bismuth nitrate in nitric acid electron micro­
scope stain pH 1.2 is highly specific for strong acid groups 
with a pK of less than 2.0, that is phosphate and sulphate 
groups in biological systems. Moreover, since the pX of 
phosphate groups are very near to 2.0, these stain only 
relatively lightly. Furthermore, since this reagent does not 
stain proteins, it results in ’’clear” areas in cells which 
have low concentrations of phosphate and sulphate groups.
This effect often gives the impression of an apparent loss 
of protein from the cells which is occasionally confused with
poor fixation.
In an electron micrograph of a lymphocyte stained with 
bismuth (Plate 7) this effect is clearly observed. It is also 
evident that the nucleus, due to its much higher phosphate ion 
content, stains more intensely than the other cytoplasmic 
inclusions, except the granules.
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Plate 4 Plate 5
Plate 4
Rat peritoneal mast cell. Simple granule stained with uranyl 
acetate, x 83000.
Plate 5
Rat peritoneal mast cell. Compound granule stained with uranyl 
acetate, x 77500.
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Plate 6
Plate 6
Rat peritoneal mast cell. Disrupted granule stained with uranyl 
acetate, x 133000.
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Plate 7
Plate 7 '
Lymphocyte stained with bismuth nitrate. This plate demonstrates 
the specificity of the bismuth nitrate stain, x 26COO.
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BISMUTH NITRATE STAINED MAST CELL GRANULES♦
Bismuth staining of mast cells produces an electron 
density in the granules which> due to their high heparin and 
hence sulphate content, is very much more intense than that of 
other components of the cytoplasm. Consequently, staining 
times which were found optimal for resolution of the granule 
substructure did not allow clear visualization of the membranes
Plates 8 and 9 show the two types of granule most 
frequently observed within the mast cells in the course of the 
present study. The simple granule (Plate 8) possesses a 
uniform particulate appearance. The compound granule (plate 
9) for the greater part exhibits an identical substructure, but 
regions of its matrix are also evident which are composed of
smaller particles that appear to be stained to a lesser extent,
conveying an impression of a more compact nature.
Plate 10 shows a granule in which a great proportion
t
of the matrix components have been released. The stained 
material appears to form beaded filaments which in some areas
coalesce or become interwoven in a loose network. A similar 
arrangement is evident in the disrupted area (a) of the granule 
in Plate 11. A reticulum composed of heavily stained bodies 
connected by beaded filaments, therefore basically similar in 
nature to that present in the disrupted areas, can be visualize* 
in the intact matrix itself (B, Plate ll). When the disrupted
region is examined in greater detail, at a higher magnification
*(plate 12) the ultrastruetural features of the network become
more evident . The particles in the heavily stained bodies 
show a considerable variation in size, whereas the diameter 
of the particles arranged in the filaments averages •
. th ns ',rat( « »’ pound
Plate 8 Plate 9
Plate 8
Rat peritoneal mast cell stained with bismuth nitrate. Simple 
granule showing a homogeneous particulate matrix, x 63000.
Plate 9
Rat peritoneal mast cell stained with bismuth nitrate. Compound 
granule in which an area of low electron density is evident, 
x 59000.
Plate 10
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Plate 10
Rat peritoneal mast cell stained with bismuth nitrate. Granule 
in which a large proportion of the matrix has been released. 
Stained particles are arranged in filaments which tend to form 
a network in discrete areas, x 87500.
71Plate 11
Rat peritoneal mast cell stained with bismuth nitrate. Granule 
showing a disrupted area (a) and a portion of still intact 
matrix (B). x 92500.
Plate 11
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Plate 12 .
Enlargement of an area from A in Plate 11. x 420000
Plate 12
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DISCUSSION
The heparin content of the average mast cell has been 
reported to be in the range 30-40 uug (Benditt, Arase & Roeper, 
1956). If a heparin-protein complex is to be isolated in 
appreciable quantities, therefore, it is essential to extract
a tissue which is rich in mast cells and, from the research 
of Riley (1959)» it appears that ox liver capsule is such a
tissue•
The procedures hitherto devised for the isolation of 
protein-polysaccharide complexes have employed high-speed
homogenisation in the presence of water or salt solutions 
(Schatton & Schubert, 195^5 Malawista & Schubert, 1958? 
Partridge, Davis & Adair, 1961). These methods rely for 
their effectiveness on a large amount of free protein-poly­
saccharide in the tissues. It is known that heparin has the 
property of binding to collagen (Serafini-Fracassini, 1967)*
lipids (Bernfield, Donahue & Berkowitz, 1957) and other 
materials (Korn, 1959)* Since the major component of ox liver 
capsule is collagen, high-speed homogenisation in water or salt
solutions alone would result in the release of the heparin from
the mast cells followed by its immediate association with the
collagen fibres. In this study, this was prevented by the use
of cetylpyridinium chloride, which effectively blocks the
sulphate groups on the polysaccharide without decreasing its 
solubility, if in the presence of 2M-potassium chloride (Scott, 
i960). Moreover, cetylpyridinium chloride is a well known
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deprotoinizing agent and allows fractionation of heparin from 
other mucopolysaccharides and DNA present in the extraction 
medium by stepwise dilution of the initial supernatant. The 
subsequent dissociation and removal of the cetylpyridinium ions 
involves the use of a chloroform-pentan-l-ol mixture which 
would remove any residual non-covalently bound protein (Blix 
& Snellman, 19^5)*
This isolation procedure does not involve the use of 
either alkali or enzymes which would cause degradation or 
modification of both protein and polysaccharide components. 
There is the possibility, however, that during the initial 
manipulation of the capsule material some degradation of the
heparin-protein complex could occur due to the action of
trypsin-and chymotrypsin-like enzymes that are known to be 
present in mast cells (Benditt & Arase, 1959» Lagunoff &. 
Benditt, 1963)» but, since trypsin is known to be inhibited by 
low concentrations of soaps (Peck, 19^2), and the stability of 
both enzymes is temperature dependent, particularly at neutral 
pH (Anson & Mirsky, 193^1 Eisenberg & Schwert, 1951)» It is 
considered that a combination of a high concentration of 
detergent and potassium chloride, at a temperature of 50°C 
which is used in the isolation procedure, would prevent hydro­
lytic damage.
The isolated material behaves, during ultracentrifugal
analysis, as a single peak characterized by a sedimentation 
coefficient of 1.85S at a concentration of 0.95% (w/v). It 
is considered, however, that the ultracentrifugation pattern
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alone does not exclude the possibility of contamination by
either non-covalently bound protein or glycopeptide-like
materials (Braswell, 1968). However, the preparation examined, 
once freed from cetylpyridinium chloride, behaves as a single
component during ethanol fractionation and requires high
concentrations of both ethanol and potassium acetate before
precipitation. It is considered that in such an environment
it is highly unlikely that any protein or peptide not covalently
bound to heparin would not be removed. Further, the results of
chromatography for neutral sugars show that only xylose and
galactose are present in conformity with the accepted linkage 
region of heparin to protein (Lindahl & Roden, 1965)• In 
addition, Serafini-Fracassini et al. (1967) have reported that 
the protein-polysaccharide of bovine nasal cartilage purified by 
cetylpyridinium chloride precipitation has a lower protein 
content than material prepared by the method of Gerber et al. 
(i960). Lindahl (1969) has criticized the use of cotylpyridinium 
chloride as a purification agent on the grounds that there is a 
danger of this compound co-precipitating non-covalently bound 
protein. The fact, however, that cetylpyridiniura chloride 
purification yields a cartilage proteoglycan having the 
lowest protein content of all the various methods employed 
appears to contradict these objections. Moreover, Sidera & 
Hascall (1969) have shown that chondromucoprotein purified 
using cetylpyridinium chloride has an amino acid composition
virtually identical to that of material prepared by the
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dissociation method using guanidinlum chloride.
The results of polyacrylamide gel electrophoresis show
that, although two heparin proteoglycan regions could be
identified in gels by their characteristic metachromasia, after
staining with toluidine blue, no orthochromatic bands could
be observed. Furthermore, when the gels were stained with
amido black, no bands of any description could be seen,
indicating that the protein moiety of the material acts as an
integral part of the complex during gel electrophoresis.
The molecular weights of the complex, as determined
by both N-terminal analysis and osmometry, are in close
agreement (19500 and 20600 respectively). Moreover, the 
average molecular weight for the heparin chains (11300), 
determined from the xylose content of the material, is in
good agreement with the values for the complex as a whole,
where two heparin chains are considered to be joined by the
protein moiety. If protein contamination had occurred, then
the most likely component of the mast cell to be involved is
the chymotrypsin-like enzyme which has been reported to exist 
in association with the heparin in the granules (Lagunoff, 1968), 
but since this enzyme has a molecular weight of 23000 (Pastan 
& Almqvist, 1966) this would not be compatible with the
molecular weight of the isolated material. Furthermore, this
enzyme is known to dissociate from the heparin at potassium
chloride concentrations in excess of 1.0M. It is considered,
therefore, that the protein component (13.2$ of the material)
Ti
is entirely covalently bound to the polysaccharide.
In view of the overall similarity of the protein 
moieties of the complexes of heparin and chondroitin 4-sulphate 
(Serafini-Fracassini, Peters & Floreani, 1967)# a comparison of 
their amino acid composition is of interest. In both cases,
proline, glycine and glutamic acid are the most frequent
residues. On the other hand, the serine concentration is
decreased in the heparin proteoglycan and becomes equimolar
with those of threonine and valine. Many of the other amino 
acids show slight variations between the two complexes, the 
major differences being the exceptionally low tyrosine content 
and the appreciable cysteine or cystine content of the heparin- 
protein complex. The presence of the latter amino acids suggest 
that the protein moiety of the complex could play some 
structural role in the organisation of the mast-cell granules.
The recovered polysaccharide constitutes approximately 
82f>, of^the complex and contains 18.1$ hexosamine 33.9 > hexuronic 
acid and 10.p sulphur. These values are in close agreement 
with the analyses of purified heparin fractions reported by 
Lindahl et al. (1965)« It has been generally accepted, for no 
apparent reason, that heparin gives high colour yields in the 
carbazole reaction (Dische, 19^7I Bitter & Muir, 1962), but 
Perlin, Mezurek, Jacques <5> Kavanagh (1968) suggested, from the 
results of proton-magnetic-resonance studies on commercial
heparin preparations, that the polysaccharide may consist of
a repeating trisaccharide composed of equimolar amounts of
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L-iduronic acid, glucuronic acid and glucosamine, If this
is the case, the values reported in Table 3 for hexuronic
acid would be absolute and the sum of all analytical values
for the complex would be correct. The high sulphur content
of the preparation indicates that the polysaccharide undergoes
very little, if any, modification during the extraction
procedure•
A further proof of the covalent nature of the complex
can now be obtained by chemical means, that is by demonstrating 
that during p-carbonyl elimination the glycosaminoglycan is 
cleaved from the protein moiety, as shown by the results of
chromatography on AE-cellulose• Moreover, a comparison of 
the amino acid analyses reported in Table 4, columns (a) and 
(b) reveals that, during p-carbonyl elimination with 0.5M- 
sodium hydroxide alone, only the threonine content is 
significantly reduced, by 19«1^. When the material is 
subjected to p-elimination and hydrogenation in the presence of 
Adams catalyst (Table 4, column C), many other component amino 
acids are destroyed to an appreciable extent. In view of the
chemical similarity of threonine and serine on the one hand,
and glycine, alanine, leucine, isoleucine and valine on the
other, it would be expected that each of these two groups, 
under identical conditions would be degraded in similar
proportions. However, in fact, the threonine content is more 
drastically reduced (33»8$) than that of serine (5»7$)» and 
the destruction of glycine is only 12.9/°* whereas that of 
alanine, leucine, isoleucine and valine averages 28.0$.
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Threonine, therefore, suffers a great deal more destruction
than would be expected from catalytic hydrogenation alone,
whereas glycine shows a relative increase in proportion to its 
related compounds. Further (K-aminobutyric acid was detected 
in the hydrolysate of the treated material. These results 
sugt est the conversion of threonine into glycine and/X'-amino- 
butyric acid, and such a conversion would be in keeping with 
the p-elimination mechanism for threonine involved in an 0- 
glycosidic linkage (Adams, 1965} Seno, Meyer, Ander\on & 
Hoffman, 1965)* ■
Lindahl & Roden (1965)> on the other hand, from their 
study of commercial heparin preparations isolated mainly from 
pig tissues, by using either proteolytic enzymes or alkali,
concluded that serine is involved in the heparin-protein
linkage. Although our results appear to be completely at
variance with these earlier findings, it is important to
point out that in the course of both investigations only 30 .
of the total theoretical number of linkages have been
analysed, and also that the complex examined during the 
present investigation was isolated by a different procedure
from a different tissue and animal species.
Kaplan (1*767) has studied the linkage region of a 
heparatin sulphate-protein complex isolated from the urine of 
patients suffering from mucopolysaccharidosis III. The
major residual amino acid in hydrolysates of this material,
after digestion with pepsin and trypsin, was serine, indicating
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that this amino acid is involved in the linkage region, in 
conformity with the results of Muir (1958). On the other 
hand, when the heparan sulphate-protein com].lex was subjected 
to B-elimination in 0.5M-K0H, at room temperature, for ^4h, 
there was no significant loss in serine content. Instead,
only threonine showed any significant loss in concentration. 
While it is conceivable that the results of p-
elimination, both in the present investigation and that of 
Kaplan (1967)» may be misleading, it seems strange that 
identical treatment of tho protein-polysaccharide of bovine
nasal cartilage results in a decrease in serine concentration 
(Anderson, hoffi.an / Meyer, 1905)• Moreover, after p-carbonyl 
elimination of the heparin proteoglycan in the presence of 
Adams catalyst, under hydrogen, ^(-arainobutyr i c acid was
detected in hydrolysates, confirming that elimination had, in 
fact, occurred at a threonine residue (Adams, 1905)* This 
apparently contradictory behaviour of both complexes can be 
explained in two ways. Kaplan (1967) has suggested the 
possibility of serine being an integral part of the glyco-
saninoglycan chains, in a similar way to sialic acid and
methylpentose present in other mucopolysaccharides. This
expl .nation, however, seems unlikely. An alternative, also 
proposed by Kaplan (1967)• i® that linkage through, serine 
is the most frequent type, although a smaller number involving
threonine are also present, The xylosylserine linkages,
however, are lkali-otable due to either a free amino or free
carboxyl group on the amino acid. hile the results of amino
end-group analysis of the heparin proteoglycan preclude the
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possibility of a serine residue with a free amino group, it 
remains possible that the serine residue involved in the 
linkage of heparin to protein may be at the C-terminal position 
of the protein moiety.
The tyrosine content of the material increases from 
6*3ug per lOmg of material after a normal 24h hydrolysis to 
32.7ug per lOi.-tg material after p-elimination alone and 35«2ug 
per lOmg material after p-elimination and catalytic hydro­
genation, It is impossible to bay, at present, whether this 
behaviour is due either to O-substitution of tyrosine in the 
heparin proteoglycan, or some compound produced during p- 
elimination which overlaps the tyrosine peak in the amino acid 
analyser, thereby producing an apparent increase in tyrosine
content•
The anticoagulant activity of the complex is 
appreciably lower than that of commercial heparin preparations 
of similar sulphur content. However, it is recognized that,
in addition to sulphur content, other molecular features such
as size and shape of the polysaccharide influence its biological
. / X Xproperties (Jensen, Snellman & Sylven, 19^8| Laurent, 19blj 
Stivala & Liberti, 1967)* Since heparin chains, once arranged 
in a macromolecular complex with protein, presumably change
their conformation, it is impossible, at the present time, to
correlate the chemical composition of the heparin proteoglycan
and its anticoagulant activity
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Electron microscopy of the preparation, after the 
first alcohol precipitation, stained with bismuth, (plates 
1, 2) reveals that a proportion of the material appears as 
beaded filaments of indefinite length composed of particles 
Of 35X average diameter. In a previous electron microscope 
study on the light fraction of bovine cartilage mucoprotein, 
using the bismuth staining technique, Serafini-Fracassini & 
Smith (1966) have reported that tho chondroitin 4-sulphate- 
protein complex macromolecules were visualized as beaded
strands of 1200a average length, consisting of 20-25 particles, 
30X in diameter. These findings were in conformity with the 
model propose1 on physicochemical evidence, by Ma—thews & 
Lozaityt© (195^) consisting of a central protein core, unstained 
by bismuth under the experimental conditions, carrying
laterally extended chondroitin sulphate chains, at regular
intervals. It is interesting, therefore, to compare the
morphology of the chondroitin 4-sulphate-protein complex and 
that of the heparin-protein complex shown in Plate 2. Both 
macromolecules, in fact, appear as beaded filaments composed 
of particles of similar size. The slightly larger particle 
diameter of the coiled heparin chains, 35*? average, is 
probably due to its higher sulphate content, which results in 
a more intensely stained and better-defined particle. It 
is therefore, postulated that both macromolecules have a 
similar arrangoment of the protein core and glycosaminoglycan
chains
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In the case of the heparin proteoglycan, however,
these long beaded filaments represent only a small proportion
of the material, the greater part occurring either as short
beaded filaments, individual particles or structureless
aggregates.
After repeated alcohol fractionation, long filaments
were no longer observed, instead, the preparation appeared as
short beaded filaments or individual particles, with an average 
diameter of 33^ (plate 3» arrows a). It is impossible, at 
the present time, to decide whether the absence of long 
filaments in this highly purified preparation reflects 
depolymerization occurring during the purification procedure, 
or if the long filaments constitute part of the 4o£ insoluble 
fraction, implying polydispersity of the macromolecules present
in the extraction medium. It is interesting to note, however,
that a similar type of depolymerization of the light fraction
of the protein-polysaccharide complex of bovine nasal cartilage
can occur along the core of the niacromolecule under conditions 
in which proteolytic degradation cannot be invoked (serafini- 
Fracassini & Smith, 1966).
The highly purified heparin preparation, when subjected
to column chromatography on agarose, separates into four 
fractions. The major fraction (F IV) has been extensively 
chemically and physicochemically characterized.
A comparison of the chemical composition of fraction 
F IV (Table 6) with that of the highly purified total heparin
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proteoglycan extract (Table 3) reveals that both fractions are 
basically identical, save for the higher xylose content of the
former. It is important to point out, however, that during
the anthrone reaction with the highly purified total extract 
some interference was observed (see Results). It Is considered 
therefore, Chat the xylose content determined for F IV is more
accurate.
The amino acid analyses of both fractions are also 
basically identical (Tables 2, 5)» save for the high glycine 
and low histidine content of F IV.
Serafini-Fracassini (1968) has proposed a model for 
the protein-polysaccharide complex of bovine nasal cartilage 
in which the macromolecular unit is composed of three 33000 
molecular weight sub-units, each of which itself consists of 
a central polypeptide core and two laterally extending glyco­
saminoglycan chains. Many of these molecular units are
linked in an end-to-end arrangement to form the overall
macromolecule•
This model is based on the formation, after treatment
of the protein-polysaccharide complex with acidic acetone pH 
5.0, of two fragments characterised by sedimentation coeffici­
ents of 2.3B and 6.1S respectively. Amino-end group analysis 
of the acidic acetone treated material reveals the presence of
four N-terminal amino acids 1 aspartic acid, valine, leucine
and isoleucine in molar ratios of 1i1iO.7«O«3 The xylose
content of the material is compatible with the presence of 
two polysaccharide chains per peptide core. The presence of 
an appreciable amount of keretan sulphate in the 8.IS unit 
and a lower concentration in the 2.3S unit suggests a 
possible role for this glycosaminoglycan in cross-linking
the sub-units.
In view of the overall similarity of the chondroitin 
4-sulphate complex of bovine nasal cartilage and the heparin- 
protein complex of ox liver capsule on both morphological and 
chemical grounds, it is interesting to examine this proposed 
model with respect to the molecular structure of the heparin
proteoglycan•
In an electron microscope study of the light fraction 
of cartilage mucoprotein (Serafini-Fracassini & Smith, 1966), 
using the bismuth staining method, the protein-polysaccharide 
molecules were visualized as beaded strands of 1200X average 
length, consisting of particles 30X in diameter. However 
shorter segments of the material were also observed indicating
that fragmentation of the macromolecules can occur under
conditions in which proteolytic degradation is impossible.
A similar situation is apparent in samples of the heparin 
proteoglycan as previously described.
The heparin proteoglycan separates on agarose into
four fractions, the majority of material being in a single 
peak characterized by a Stokes radius of approximately 32.5^» 
although an appreciable amount of material is present in a
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fraction of 9^5? stokes radius and two fractions containing 
small amounts of material of considerably higher molecular 
weight were also detected. Bovine chondromucoprotein, after 
treatment with acid acetone, and separation on agarose, 
produces a similar elution pattern, the fraction corresponding 
to the 2.3S sub-unit having a Stokes radius of 47*5^ and the 
8.1S fraction is eluted at a Stokes radius of 135^ (Serafini- 
Fracassini & Stimson, 1969)* The number average molecular 
weight of the he,-arin proteoglycan is approximately 20000, 
when determined by osmometry and amino-erid group analysis.
On the other hand, a number average molecular weight of 11000
is derived for the heparin chain from its xylose content.
These figures are in agreement with the proposal that the
heparin proteoglycan macromolecules, as visualized by electron 
microscopy, both in extracted materia 1 (Plate 2) and within 
the mast cell granules (Plate 12), are composed of sub-units, 
each of which itself consists of a central polypeptide core
carrying two laterally extending heparin chains. This
proposal is in agreement with the model reported by Serafini- 
Fracassini (1968) for th© protein-polysaccharide complex of 
bovine nasal cartilage. It is impossible to say at the 
present time, whether the arrangement of these sub-units 
forming the large macromolecules is identical to that proposed 
for the chondroitin 4-sulphate-protein complex, but a peak 
corresponding to a trimer was Identified (F III), characterized 
by a Stokes radius of approximately
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Although amino-end group analysis of the heparin 
proteoglycan, unlike that of the chondroitin 4-sulphate- 
protein complex, yields no precise molar relationship between 
the various residues, it must be remembered that the chondroitin 
4-sulphate complex is isolated as a inacromolecule and 
subsequently reduced to its constituent sub-units, thereby 
producing a homogeneous mixture of the various molecular 
species present in the macromolecule. On the other hand, it 
appears that the majority of the heparin proteoglycan macro­
molecules are extracted in sub-unit form, and the heterogeniety 
of the N-terminal amino acids may merely reflect losses at 
the isolation stage.
The appreciable cystine or cysteine content of the 
heparin-protein complex (2 residues per polypeptide core) 
indicates their possible involvement in the structure of the
heparin proteoglycan macromolecules. Treatment of the
isolated material with 2-mercapto-ethanol, on the other hand,
does not produce any results which might clarify this
situation. The removal of the heparin proteoglycan from the
mast cells by 2M-KC1 extraction, observed by many authors 
(Bloom & Haegermark, 1965$ Lloyd, Bloom A Balazs, 1967$
Lloyd, Bloom, Balazs & Haegermark, 1967) tends to indicate 
that the heparin proteoglycan macromolecules do not involve
disulphide bridges, although it must be pointed out that these
authors did not study the molecular characteristics of their
extracted material
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The electron microscopic appearance of rat peritoneal
mast coll granules stained with uranyl acetate is shown In 
Plates 5 A 6. Although this method is insufficiently 
specific to allow the study of the ultrastructure of the mast 
cell granules with respect to its heparin component, it shows
that the general appearance of the cells studied in this
thesis is similar to that reported by other investigators using 
the same stain (Bloom & Haegermark, 1965; Welnstock 4 Albright, 
1967t Kobayasi, Midtgard & Aboe-Hansen, 1966). The
lymphocyte, stained with bismuth nitrate in nitric acid pH 1.2,
demonstrates the highly specific nature of this reagent.
Examination of the disrupted region of a rat peritoneal 
mast cell granule (Plate ll) reveals a network of beaded 
strands connected by large electron dense bodies. At a
higher magnification Plate 12 these beaded strands can be 
seen to be composed of particles of 35^ average diameter. A 
comparison of these beaded strands with the filaments in
Plate 2 reveals that the particles in both materials have 
identical diameters. Since the staining method is highly 
specific for components containing acidic groups of low pK,
it is considered that the beaded filaments in Plates 2 & 12
represent heparin proteoglycan macromolecules, composed of a
protein core with lateral chains of glycosaminoglycan in
coiled conformation. The presence of colled polysaccharide
chains in fixed and embedded material is to bo expected since
it has been shown that the conformation of heparin in solution
is that of a Gaussian coil with a radius of gyration of 
approximately 3^*5% (stivala et al., 1968). The reduction 
in size of the coils is probably due, in the fixed and
embedded material, to dehydration occurring during the
preparation of tbe histological specimens, and, in the
isolated material, due to the cross-linking of bismuth ions
which would tend to produce a more tightly coiled macro­
molecule.
The a ope trance of the large electron dense bodies, 
which are frequently in continuity with the terminal portion' 
of the filament in Plate 12 suggests that they are probably 
caused by folding of the protein core resulting in adjacent 
heparin chains becoming entangled. In such a case, the
size of the particles is no longer related to individual
chain size, but becomes a function of tho degree of
entanglement. This interpretation is supported by the fact
that entanglement probably also occurs in very dilute
solutions, as demonstrated by the existence of particles of 
large diameter in both sample 1 and sample 2 of the isolated
heparin proteoglycan. This is the reason why molecular 
weight determinations were carried out by osmometry and 
amino-end grouj analysis, and not by equilibrium sedimentation 
The former methods are not affected very much by interference 
due to entanglement, whereas equilibrium sedimentation gives 
a weight-average molecular weight which tends to emphasize 
disproportionately the higher molecular weight species present
89.
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The continuity in particulate appearance from the 
filaments into the still intact area of the granule (Plate 11) 
suggests that elongated macromolecules constitute a large
proportion of the granule matrix. It is therefore proposed,
that the mast cell granule is composed of a network of heparin-
protein macromolecules bound, by means of their intense
negative changes, with the basic components of the matrix.
This interpretation is in line with the work of Uvn&s & fhon 
(1965) who demonstrated that histamine is released from the 
mast cell granules by an ion exchange mechanism. Bloom & 
Haegermark (1905), from their study of induced histamine 
release from rat peritoneal mast cells, using the compound 48/80 
observed that 757° the heparin remained inside the mast
cell after histamine release, indicating that the heparin- 
histamine binding is electrostatic. Lagunoff (1968) has proved 
that the chymotrypsin-like enzyme is bound to heparin in an
active form, but on the addition of NaCl in excess of 1M,
this complex dissociates, this behaviour being indicative of
electrostatic interaction.
The compact regions of tho matrix in the compound 
granule (plate 9) could consist of macromolecules either with 
a low degree of sulphation or with their negative changes
almost completely neutralised by positive groups. Either of
these possibilities, in fact, would result in a low uptake of
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bismuth ions,
these areas.
as revealed by the low electron density of
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SUMMARY.
This thesis reports!
1) . A procedure for the isolation and purification of the
heparin proteoglycan from ox liver capsule, based on
the solubility properties of inucopolysaccharide-cetyl- 
pyridiniurn complexes is reported. The yield of the 
heparin proteoglycan averages 35 mg/lOOg of dry ox 
liver capsule.
2) . The chemical analysis of the heparin proteoglycan of
ox liver capsule is reported. The results of analyses 
♦on the polysaccharide show good agreement with values
previously published for purified hoparin fractions.
The amino acid analysis shows several similarities to
that of bovine chondromucoprotein. The results of 
p-carbonyl elimination, either with or without catalytic 
hydrogenation, and column chromatography after p- 
elimination, show that the polysaccharide is covalently 
bound to protein, probably through a xylosylthreonlne
link •
3) . Column chromatography on agarose reveals that the
heparin proteoglycan separates into four fractions. 
Chemical analysis and amino acid analysis on the major 
fraction shows that it is basically identical to
untr ated material. Amino-end group analysis reveals
the presence of four N-terminal amino acid residues.
4) . The major fraction of heparin proteoglycan obtained
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after column chromatography is characterised by a 
Stokes radius of approx. 32•5$• A number-average 
molecular weight of 20000 is obtained for this fraction
from the results of osmometry and amino-end group
analysis. A number-average molecular weight of approx.
11000 is reported for a heparin side chain, based on
its xylose content.
5) . The heparin proteoglycan, isolated from ox liver capsule,
has been studied by electron microscopy after staining
with bismuth nitrate. The macromolecules appear as 
beaded filaments composed of particles of 35^ average 
diameter.
6) . The substructure of the mast cell granules has been
examined, using the same staining technique. The 
matrix of the intact organelle is heavily stained and
exhibits a homogeneous particulate appearance. When 
the granule disrupts, the matrix becomes less compact,
revealing a network of fine beaded filaments. Tho 
average diameter of the particles arranged in these 
filaments is 35^.
7) . It is proposed that the mast cell granule is composed
of a random network of elongated heparin proteoglycan
macromolecules around which the other components of
the matrix are arranged. It is further proposed that
the macromolecules themselves consist of subunits of
20000 molecular weight, each of which is composed of a
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polypeptide core and laterally extending heparin chains. 
Many of these subunits are joined in an end-to-end
arrangement to form the inacroniolecules.
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AfP^NDIX.
ISOLATION OP TL/lCPAftlN PROTEOGLYCAN FROM OX LIVER CAPSULE,
During the preparation of this thesis, a paper has" 
been published critising the isolation method described in 
the present investigation, Lindahl (1970) has attempted to 
isolate the heparin proteoglycan of bovine liver capsule by
a procedure which involves extraction with 2M-KC1, at low
temperature, and subsequent purification with cetylpyridinium
chloride, as followss«
lOOg of ox liver capsule, homogenised by passage through 
a bacterial press, was suspended in 200ml water and gently 
stirred for JOmin at 0°C. After centrifugation, the 
extraction was repeated once with water and three times with 
2M-KC1, at 4°C. Samples of each extract were tested with 
cetylpyridinium chloride and only the initial 2M-KC1 extract 
was found to contain any significant polysaccharide content,
This KOI extract was clarified by filtration through celite, 
and precipitated from 0.8M-KC1, containing 0.023M-tris buffer 
pl£ 9*0, by cetylpyridinium chloride, the mixture being allowed 
to stand at 30°C for JOmin to allow precipitation. The 
precipitate was then redissolved in 2M-KC1 and reprecipitated 
by adjustment of the KC1 concentration to 0.8M. This second 
precipitate was suspended in 2M-NaCl in 10% ethanol (v/v) at 
30°C, which removed the cetylpyridinium chloride. The
polysaccharide fraction was finally precipitated by the addition
of a further 3 volumes of ethanol, collected by centrifugation,
washed with ethanol, and dissolved in 5ml of water. This
fraction was then subjected to digestion with hyaluronidase for
17h. After di estion, the pH was adjusted to 9*0 and the
remaining mucopolysaccharide precipitated with cetylpyridinium
chloride and recovered as its sodium salt as previously
described. The material was then converted to its calcium salt
and fractionated in ethanol by the method of Meyer, Davidson, 
Linker & Hoffman (1956). The fraction which was precipitated 
from 5O'*j ethanol was collected, converted into its sodium salt
and freeze-dried.
Analysis of this fraction revealed a uronic acid 
content of 25.8 and a hexosamine content of 20.2*$ (these 
values were not corrected for moisture). Glucosamine was
reported to constitute 9®» of the total hexosamine and a
z
sulphur content of 2.2 moles per mole of hexosamine was
obtained. The weight-average molecular weight of the
material, as determined by equilibrium ultracentrifugation, 
was 7^00 and its protein content was 3$.
If this material is, in fact, the true native heparin
proteoglycan, and our material, as reported by Lindahl (1970)
1is an artifact due to the non-covalent binding of heparin to a
protein contaminant, then the results presented in this thesis 
would be severely undermined. It is, therefore, necessary to 
examine in detail the results obtained by Lindahl (1970) and 
compare them with the analysis of the preparation studied in
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the present investigation
9?
It is implied, by Lindahl (1970)» that the same 
extraction procedure is employed in both cases. The procedure 
used in the present investigation, however, involves homo­
genisation in 2M-KC1, containing lr (w/v) cetylpyridiniura 
chloride, preheated to 50°C prior to the addition of dried ox 
liver capsule, thus ensuring the prevention of any proteolytic 
enzymic activity. Lindahl (1970), on the other hand, pre­
extracts ox liver capsule with water followed by 2M-KCX and 
subsequent purification using cetylpyridinium chloride. While
enzymic activity may be prevented, during extraction, by the
use of low temperatures, the exceptionally low molecular weight 
of the final heparin jreparation (7^00) has required Lindahl 
(1970) to propose the existence of a polysaccharidase with 
endoenzyme properties, which he claims has degraded the heparin 
moiety of the extracted complex. If an enzyme of this type is 
present in mast cells, then it would appear likely that under 
the conditions required for its activity, the trypsin-like and 
chymotrypsin-like enzymes, known to be present within the mast 
cell granule itself, would probably degrade the protein moiety 
of the heparin proteoglycan. The proposal that the chymo- 
trypsin-like enzyme is electrostatically bound, in an active 
form, to the heparin-protein complex within the granules 
(Lagunoff, 1968) tends to confirm this observation. In 
addition, the fact that newly-synthesized polysaccharide is 
rapidly degraded in mastocytoma cells is not entirely relevant 
since it has already been reported that heparin isolated from
this type of coll contains no covalently bound, protein (Korn, 
1959). Moreover, the metabolism of tumour cells is known to 
be considerably different from that of normal cells, making a
di roct comparison of their chemical components impossible,
' ' ' • “ '■ 1 '* ■The many techniques employed to ascertain tho covalent
nature of the protein moiety of the protein-polysaccharide
studied in the present investigation have already been discussed 
at length. Tho removal of non-covalently bound protein 
contamination, by Lindahl (197O)» performed by repeated re­
precipitation of the cetylpyridiniura derivative by dilution of 
the 2M-KC1 extract to O.iM-LCl. However, the observation by 
Lindahl (1970) that non-covalently bound protoin contamination 
was identified even at the final alcohol precipitation stage
of the preparation procedure implies that thi3 procedure was
insufficient. Removal of cetylpyridinium chloride in the
present extraction procedure was effected by shaking with 
chloroform:pentan-l-ol (5»^» v/v), which is itself an accepted 
method of removing non-covalently bound protein (Dlix & Snell- 
man, 19^5)* and the aqueous layer was chocked for residual 
cetylpyridinium chloride by the disappearance of its character­
istic ®2t,Q Peal<* In addition, after dialysis against distilled 
water, the material was repeatedly fractionated from ethanol
containing potassium acetate, which it is considered would
• •remove any residual protein or peptide bound through electro­
static forces
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The use of cetylpyridinium chloride in the initial
extraction medium allows the fractionation of the heparin free
from other mucopolysaccharides and DNA. by stepwise dilution
of the initial supernatant to 0.9M-KC1. A galactosamine
content of only 3.6^, when expressed as percentage of total 
hexosamine, obtained for material purified in this manner
confirms that there is very little, if any, contamination by
dermatan sulphate. Some commercial heparin preparations have
boon reported to contain 5•galactosamine, expressed as 
percentage of total hexosamine (Radhakrishnamurthy et al., 
1968a). Lindahl (l97O)» on the othor hand, by dilution 
of a 2M-KC1 extract to O.SM-KCl, recovers a fraction which 
contains 28'*> galactosamine. This method, therefore, requires 
subsequent digestion with hyaluronidase to remove the dermatan 
sulphate, tho galactosamine content after this treatment being
reduced to 2' of the total hexosanine.
Amino acid analysis of the heparin proteoglycan 
isolated by Lindahl (1970) Is reported as residues per muco­
polysaccharide chain, and only tho most abundant amino acids
are tabulated. After alkaline treatment in 0.5M-Na0H for 20h 
at U°C, amino acid analysis reveals, in agreement with similar 
experiments carried out in the present investigation, that the
serine content is relatively increased, indicating that the
xylosylserine linkage may be at the C-terminal position of the 
polypeptide. However, whereas after alkaline treatment of the 
heparin proteoglycan in the present work the serine concontratlo
ICO
was in fact reduced, but rel.-tively less so than the other 
amino acids, Lindahl (1970) reports not only a relative 
increase in its content, but an actual increase in its total
concentration compared with untreated material. Moreover, it
would appear that in the material subjected to alkaline
treatment there is an increase in total protein content 
compared with untreated material (I)•
When heparin is extracted from ox liver capsule, 
after digestion witl papain (Lindahl, 1970), the overall 
protein concent is, as expected, considerably reduced. How­
ever, althou ti«< serine concentration in this material is
relatively increased•compared with material isolated under 
mild conditions, the overall amino acid pattern is basically
identical. It is interesting, therefore, to examine the
expected action of papain digestion on the heparin-protein 
complex isolated by Lindahl (1970). It is 3u,;gested that 
this complex is composed of a short polypeptide core to which
a single heparin chain is attached. The results of alkaline
treatment indicate that the heparin-protein link is probably 
through xylosylserine, the serine residue being at the C-
terminal position of the polypeptide. Papain digestion of a 
molecule of this type, therefore, would be expected to cause a
considerable reduction in its total protein content, and a
relative increase in the concentrations of the amino acids
nearest to the linkage point, that is a drastic change in the
101
overall arulno acid pattern.
Neutral sugar analysis of the material isolated by 
Lindahl (197^) reveals a xylosejheparin molar ratio of 0.12, 
based on a heparin chain consisting of 12 disaccharide units, 
each of which has a molecular weight of 6l5« While it is 
conceivable that heparin may be bound to protein through
lineages other than those involving xylose, if it is assumed
that only those heparin molecules which contain a xylose 
molecule ala covalently bound to protein, then the 3*£ protein 
content of this he arin—protein complex is covalently bound
to only 12 of the lycosaminoglycari chains. Therefore, that 
roportion of the natori 1 studied by Lindahl (1970), which 
In fact contains a covalent protein moiety possesses a protein
content of 26( •
In the discussion of his paper I indahl (197^) quotes 
the results of Lloyd, Bloom & Balazs (1967) and Lloyd et al. 
(1967) who isolated small amounts of an alkali-labile lieparin- 
lik© suateri 1 from rat mast cells and correlated these results
with electron microscone studies on degranulation of the mast
cells. Although these workers isolated insufficient material
to determine its chemical characteristics, Lindahl proposes
that the discrepancy between the results of his own investigat
ion and this previous study might be ascribed to inherent
vnriatior s m om different tyjes of ma t cells. However, the
natf rial isolated by 1 indahl (197^) was not alkali-labile
In view of the very low molecular weight of the 
preparation (7^00), considerably lower than that reported for 
some heparin fractions (Lasker & Stivala, 1966} Stivala et al 
1967; Braswell, 1968), and the poor xylose:heparin molar 
ratio, it is considered that this preparation represents a
heparin-protein complex which has suffered extensive
enzymatic degradation. Moreover, it has been established 
(see Discussion) that tho protein moiety of the heparin 
proteoglycan isolated using the procedure described in this
thesis is entirely covalently bound to heparin
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